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4 Abstract 
 
The intestinal immune system is daily threatened by the exposure to potentially harmful 
agents, such as food antigens and the gut flora. They represent, indeed, a potent 
immunogenic stimulus that the immune system has to tolerate. 
In the Gut-Associated Lymphoid Tissue, the cooperation and mutual interaction of specific 
environmental factors and peculiar populations of antigen-presenting cells renders the gut 
a suitable site for the maintenance of a tolerogenic milieu, where immunosuppressive 
mechanisms keep at bay unwanted deleterious immune responses.    
The establishment of tolerance to food antigens mostly relies on the ability of specific 
subsets of mononuclear cells to take up antigens in the SI (Small Intestine) and to 
subsequently shape the immune response, which is initiated in the draining mesenteric 
lymph nodes. 
Here, we describe a subset of resident intestinal macrophages, expressing CX3CR1, 
which are committed to antigen uptake. Furthermore, we show that in the absence of 
functional CX3CR1 receptor, which impairs the ability of these cells to sample the intestinal 
lumen, decreased antigen uptake and failure in the establishment of oral tolerance is 
observed in CX3CR1-deficient mice. 
As CX3CR1
+ cells are sessile and poorly able to prime T cells, we hypothesized the 
possibility of gap junction-mediated antigenic material transfer to CD103+ dendritic cells, 
which have been accounted for migratory tolerogenic cells. We show, indeed, that 
mononuclear cells from the SI can exchange peptides and gap-junction diffusible dyes. 
Furthermore, CX3CR1
+ macrophages and CD103+ dendritic cells express a peculiar panel 
of connexins, among which connexin 43 is the most expressed. 
We then generated mice lacking connexin 43 in CD11c+ cells. These mice displayed no 
change in the frequency and activation state of the different populations of lamina propria 
cells but decreased the levels of peripheral T regulatory cells at steady-state. In addition, 
we observed impaired establishment of oral tolerance to ovalbumin. This indicates that 
DC-expression of Cx43 is required for the establishment of oral tolerance. Whether this is 
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due to a lessening in antigen transfer which impinges on the ability of CD103+ dendritic 
cells to prime T cells towards a tolerogenic phenotype or to other Cx43-dependent 
functions of SI mononuclear cells are still open questions, which need to be addressed. 
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5 Introduction 
 
The gastrointestinal system consists of a hollow muscular tube going from the mouth to 
the anus, primarily implicated in the digestive process. As a result of its main function, the 
mucosal surface of the GI tract is daily exposed to food antigens introduced with the diet. 
Such a high antigen load represents a potent activation stimulus the immune system has 
to tolerate and constantly cope with. Indeed, the inappropriate activation to such harmless 
antigens (Ags) would result in tissue damage and reduction of functional efficiency of the 
organ. 
An additional layer of complexity at the intestinal level is conveyed by the commensal 
bacteria that colonize the gut and mutualistically share nutrients and ecosystem with their 
host. If only considering Pathogen - Associated Molecular Patterns expressed by these 
microorganisms, they are indistinguishable for the immune system from the pathogens 
that might be accidentally introduced via the oral route.   
Thus, a highly specialized immune system that could properly respond to this variety of 
stimuli is needed, in order to mount an effective immune response against infectious 
microorganism, as well as to induce tolerance to commensal bacteria and food antigens. 
Hence, at steady state a sort of immune privilege [1] characterizes the intestinal 
environment where regulatory mechanisms control and, eventually, suppress the 
establishment of a response against innocuous antigens encountered at the periphery.  
Immune hyporesponsiveness to bacterial and food Ags in the gut relies on diverse but 
interconnected mechanisms [2] and is established with a different range of action. Indeed, 
tolerance to fed Ags - usually referred as oral tolerance - is systemically spread, being the 
immune unresponsiveness maintained even when the same antigens are parenterally 
administered under immunogenic conditions [3, 4]. On the other hand, tolerance to 
commensal bacteria is restrained locally, as systemic immune “ignorance” towards 
bacterial Ags is pursued [5]. 
The maintenance of a balanced immune response in the gut is clinically relevant since its 
pathological alteration may lead to food hypersensitivities and allergies or inflammatory 
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bowel diseases (IBD), such as Crohn’s disease and ulcerative colitis. Together with the 
contribution of environmental factors, IBD susceptibility depends indeed on genetic 
alteration that mostly concern the ability of the immune system to correctly deal with gut 
bacteria [6].             
 
5.1 Tolerance to bacteria 
 
The intestine is colonized by a heterogeneous microflora, a complex ecosystem 
containing over 1000 identified species, sparse in the stomach and the upper intestine 
and widely present in the large intestine [7]. For instance, concentrations of 109-1011 
bacteria for gram of content are found in the human colon, most belonging to anaerobic 
genera, such as Bacteroides, Bifidobacterium, Eubacterium, Peptostreptococcus, and 
Clostridium. 
The relationship between the host and its microflora outwits the simple symbiosis (non-
harmful coexistence), but it is referred as mutualism [8]. Indeed, gut flora has been 
implicated in different functions that benefit the host, such as the absorption of complex 
macromolecules, the synthesis of vitamin K and some components of the vitamin B 
complex [9], and the prevention of the colonization by pathogenic bacteria. In fact, it 
hampers the overgrowth of potentially pathogenic members, as it physically occupies 
most available niches, limits resources and space for invading microorganisms and 
produces antimicrobial substances to inhibit their growth. 
The acquisition of a fully diversified microbiota is instrumental to the postnatal 
development of the gut immune system during the first years of life. Particularly, recent 
studies conducted in mice have highlighted the role of some bacteria, such as Segmented 
Filamentous Bacteria (SFB), in their superior ability to induce the maturation of the 
intestinal immune system [10, 11]. Also T regulatory cells induction has been associated 
to particular bacterial species, such as Clostridium spp., or bacterial components, such as 
polysaccharide A derived from B. fragilis. [12, 13].    
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In the gut, distinctive anatomical and functional features well suit the need to tolerate and 
maintain a controlled homeostasis toward intestinal flora [5, 14], namely i) the presence of 
the epithelium that physically avoid the direct contact between the intestinal immune 
system and the microorganisms confined in the lumen; ii) secreted factors, such as the 
mucus, antimicrobial peptides and IgAs, that limit the contact between the epithelium and 
the microbes; iii) system for the rapid detection and killing of bacteria that might penetrate 
the epithelial barrier, as in the case of tissue macrophages; iv) maintenance of systemic 
“ignorance” to bacteria (Figure 5-1). A general overview of these issues will be given in 
the next paragraphs.   
 
 
Figure 5-1 Immune mechanisms that contribute to the maintenance of intestinal 
homeostasis.  Distinctive anatomical and fuctional features are important to tolerate intestinal 
microbes: i) the epithelium; ii) secreted factors, such as the mucus, anti-microbial peptides and 
sIgAs; III) presence of highly phagocytic cells in the tissue; iv) maintenance of systemic ignorance 
to bacteria.  
 
5.1.1 Epitehelium  
 
The intestinal mucosa is lined by an extensive layer of columnar epithelium that provides 
both a barrier to pathogens and commensal bacteria, a selective transit for fluid and 
electrolyte absorption and secretion. The epithelium is a polarized surface, in contact at 
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the apical side with the luminal content and at the basolateral side with the immune 
compartment, consisting mostly of organized lymphoid tissue and populations of T and B 
lymphocytes and innate immune cells scattered throughout the lamina propria.  
For a long time, the epithelium has been considered as just a mechanical barrier impeding 
the uncontrolled translocation of invading pathogens, such as bacteria, virus and 
parasites. The continuity of the layer is conferred by tight and adherens junctions located 
near the apical surface of the columnar epithelium. Cell - cell adhesion at these junctions 
is maintained by complexes of proteins, such as occludins, zonula occludens (ZO) - 1 and 
-2 and members of the claudin family.  
Recently, this limited view has been broadened by the observation that the epithelium is 
not only a physical barrier but it takes an active part in immunological processes [15].  
Indeed, epithelial cells - through the expression of different Pattern Recognition Receptors 
(PRRs) - may recognize philogenetically conserved PAMPs, which are shared by 
pathogenic bacteria and non - pathogenic ones, and send signals to the mucosa beneath.  
PRRs are classified in three main groups, namely Toll - Like Receptors (TLRs), Nucleotide-
binding domain and Leucine - rich repeat containing Receptors (NLRs) and Retinoic Acid - 
Inducible gene- I - like Receptors (RLRs) [16]. They differ for their localization and ligand 
specificity; their expression is not limited to epithelial cells (ECs), but they are found in 
different cell types of the immune system, such as monocytes, dendritic cells and 
macrophages [17]. TLRs are membrane - bound, NLRs and RLRs are cytosolic.       
How epithelial cells can discriminate between gut flora and pathogens is still a topic under 
active debate. Certainly, only bacteria that are able to infect ECs and break the integrity of 
the epithelial monolayer can interact with receptors that that expressed intracellularly - 
such as NOD1 and NOD2 - or in the basolateral side of the epithelium - such as TLR5 
[18]. More precisely, as a result of tissue damage, bacteria can permeate into the tissue, 
reach EC basolater side and start a pro - inflammatory cascade, as it has been described 
for TLR5 [19].         
On the other hand, at steady - state microbes are confined into the lumen and basal PRRs 
activation from the apical side is beneficial to the maintenance of EC integrity and 
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intestinal homeostesis to bacteria. For example, a polarity - dependent response has been 
shown in vitro for TLR9 [20]. When TLR9 is stimulated from the apical side, a defective 
activation of the NF-κB pathway and a peculiar gene expression profile of apically - vs. 
basolaterally - stimulated cells have been reported. 
In vivo, this is paralleled by the observation of spontaneous development of colon 
inflammation or increased susceptibility to experimental colitis in several mouse models of 
PRRs - deficiency, such as TLR-2, -5, -4, -9 and MyD88 knock - out mice [20-24]. 
Although the use of straight knockout mice prevents to fully discern ECs’ from immune 
cells’ contribution to the phenotype, general defects in the absence of TLR signalling 
affect EC functions, including decreased proliferation and secretion of cytoprotective 
factors and increased apoptosis. Nonetheless, specific inhibition of NF-κB pathway in ECs 
by IKKγ or IKKα / IKKβ deletion [25] recapitulates the observed phenotype in the 
previously mentioned knock - out mice.      
Moreover, commensal and non - pathogenic bacteria dampen the induction of an 
inflammatory response mainly modulating NF-κB activation at different levels [26], for 
example post - transcriptionally inhibiting the pathway activator IL-1 Receptor Associated 
Kinase 1 (IRAK1) soon after birth in mice [27, 28], or stabilizing Iκ-Bα in the cytosol in 
human intestinal epithelial cell lines [29-31], or shuttling nuclear NF-κB subunit RelA out 
the nucleus [32]. Of note, prolonged stimulation with TLR agonists renders intestinal 
epithelial cells hyporesponsive to subsequent stimulation, due to reduced surface 
expression of the receptors and upregulation of negative regulators of the NF-κB pathway, 
such as Tollip [33]. 
 
5.1.2  Epithelial Cell - derived conditioning factors 
 
As the epithelium strictly interacts with Antigen - Presenting Cells (APCs) in the lamina 
propria (LP), conditioning by EC-derived products may provide an important mechanism 
for the maintenance of intestinal hyporesponsiveness by APCs. For instance, such 
conditioning renders DCs able to induce a tolerogenic T cell response in absence of 
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infection, limiting the production of pro-inflammatory cytokines. Nonetheless, in the 
presence of inflammatory signals, inflammatory cytokines and chemokines released by 
IECs would recruit a new pool of “non-conditioned” dendritic cells, competent for 
sustaining an active immune response [15].     
In vitro systems based on the co-culture of polarized epithelial cells with dendritic cells 
have led to the identification of factors that contributes to APC conditioning.  For example, 
human colonic ECs release thymic stromal lymphopoietin (TSLP), which drives a non-
inflammatory Th2 response and inhibits the capacity of monocyte-derived DCs to produce 
IL-12, a Th1-polarizing cytokine [34, 35] even when infected with S. Thyphimurium.  
Additionally, Iliev et al. showed that EC - conditioned dendritic cells promote T regulatory 
cell (Treg) cell differentiation, through a mechanism dependent on TSLP, Transforming 
Growth Factor (TGF)-β and Retinoic Acid (RA) in humans [35]. Decreased expression of 
Tslp, Tgfb1 and Aldh1a1 (which catalyzes the reaction from Vitamin A to Retinoic Acid) 
genes is observed in ECs isolated from Ulcerative colitis and Crohn’s disease patients, 
suggesting an in vivo role of these mediators in intestinal homeostasis.  
Besides, intestinal epithelial cells are able to shape the local humoral response secreting 
B-cell activating factor (BAFF, also known as TNFSF13B) and a proliferation-inducing 
ligand (APRIL, also known as TNFS13) [36] that promote class-switching of B cells toward 
the production of IgAs. Furthermore, through the release of TSLP, ECs induce dendritic 
cells themselves to release BAFF and APRIL [36].    
Once secreted, IgAs are bound to the polymeric immunoglobulin receptor (pIgR), 
translocated through IECs to the lumen and released by proteolitic cleavage of the pIgR.  
 
5.1.3 The mucus layer 
 
Secreted factors, such as mucins, anti - microbial peptides (AMPs) and secretory IgAs, are 
then released to further prevent luminal bacteria to contact EC surface.   
Mucous and goblet cells along the GI tract release mucins, high molecular weight - 
proteins characterized by extensive glycosylation [37]. Varying along the intestinal length, 
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the mucus layer is characterized by different properties, including mucin composition, 
viscosity and thickness. In the colon, where high bacterial burden is observed, the mucus 
layer is thicker, mainly made up of MUC2, and easily distinguishable in two main sheets. 
The inner one is a densely packed matrix of membrane - anchored mucins, devoid of 
bacteria [38] and rendered even more inhospitable as it concentrates EC - derived anti - 
microbial peptides and sIgAs. The external layer is looser and represents the habitat for 
intestinal flora.  
The role of mucins in the protection against invading bacteria is highlighted by increased 
susceptibility to pathogen infection reported for MUC1 knockout mice [39, 40] or to 
spontaneous colitis for MUC2 knockout mice [41, 42]. Mucins may even bind pathogens, 
as in the case of MUC1, that can be released by human gastric epithelial cells and adhere 
to Helicobacter pylori to limit its invasiveness [43].   
 
5.1.4 Antimicrobial peptides 
 
Anti-microbial peptides, such as defensins, cathelicidins and C-type lectins, are 
constitutively produced by IECs or inducibly released after PRR engagement by Paneth 
cells - specialized ECs localized at the base of the intestinal crypts [44, 45]. Various 
mechanisms account for AMP bactericidal activity, but often they interfere with membrane 
integrity and cell wall synthesis. Indeed, AMP polar structure, consisting of charged heads 
and a central hydrophobic region, allows their insertion in the bacterial membrane to form 
“pore - like” or “carpet - like” structures [46], making holes or covering bacteria that are 
finally killed. Besides, chemo-attractant and immunomodulatory properties have been 
reported for some defensins [47].  
As highly redundant in their function, single knockout mice for AMP genes are ineffective 
to prove AMP importance in the maintenance of intestinal homeostasis. Only the use of 
approaches that directly target Paneth cells or the production / maturation of AMP have 
offered valuable tools to understand AMP role in controlling the intestinal microflora and 
prevent pathogens outgrowth. For instance, Paneth cells - deficient mice, that express a 
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diphtheria toxin fragment under the control of the Paneth cell - specific cryptidin-2 
promoter, or Myd88-/- mice, that show lower expression of AMPs in the small intestine, 
display increased translocation of commensal bacteria to the mesenteric lymphnodes 
(MLNs) and increased systemic spreading of S. typhimurium [45]. In Myd88
-/- mice, the 
observed phenotype is reverted by Paneth cell - specific re - expression of Myd88.  
A similar phenotype is observed in mice lacking the gene for MMP-7 (Matrix 
Metalloproteinase-7), which is required for the processing of pro-α-defensins into their 
active form [48].    
Interestigly, the increased susceptibility of Nod2 - deficient mice to H. Hepaticus infection 
is reverted by the expression of human α - defensin 5 (HD5) [49], suggesting a connection 
to the human pathology, as Crohn’s disease patients with NOD2 susceptibility alleles 
display a reduced expression on α - defensins. In humans, also the genetic variants in the 
transcription factor TCF4, implicated in goblet cell maturation and function, has been 
associated with ileal Crohn’s disease [50].  
     
5.1.5 Secretory IgA 
 
IgAs represent a further line of defense to uncontrolled bacterial translocation through the 
epithelium and are abundantly found in the mucosal secretion. Their release into the gut 
lumen requires the formation of dimers of IgAs via the interaction with the joining (J) chain 
and the recognition by the polymeric immunoglobulin receptor (pIgR) expressed by ECs 
[51].  
B cell development begins in the bone marrow, where the exons coding for 
immunoglobulin heavy-chain (IgH) and light-chain (IgL) variable regions are re - arranged 
from variable (V), diversity (D) and joining (J) segments, through a process known as 
V(D)J recombination. Properly arranged IgH and IgL are then expressed as IgM heavy 
and light chains on newly generated B cells.  
After leaving the bone marrow, IgM - expressing naïve B cells further diversify their 
repertoire through V(D)J somatic hypermutation (SHM) and heavy chain class - switch 
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recombination (CSR), both requiring activation-induced cytidine deaminase (AID) 
enzymatic activity [52]. 
The process of SHM introduces point mutations at high rate in the variable regions of IgH 
and IgL genes and ends up with the selection of B cells producing high affinity antibodies; 
CSR consists in the substitution of the IgH constant (C)-region (Cµ) exons with 
downstream IgH C-region exons, such as Cγ, Cα and Cε. Hence, antigen specificity is 
preserved, yet the antibody isotype is changed to IgG, IgA or IgE, respectively.    
In the GALT, induction of IgA+ B cells takes place in organized lymphoid tissues, such 
Peyer’s Patches and isolated Lymphoid Follicles (ILFs) and unorganized regions, namely 
B cells sparse in the lamina propria [52].  
Different signals are required for IgA class-switch recombination and induction of AID 
expression by B cells (Figure 5-2), including soluble factors, cytokines and / or ligation of 
CD40 expressed by B cells. Engagement of CD40 by its ligand CD40L present on T cells 
is dispensable for IgA CSR, as demonstrated by almost normal secretion of IgAs in the gut 
of CD40 knockout mice [53] and of patients affected by congenital type-3 hyper-IgM 
syndrome characterized by CD40 deficiency [36].      
Indeed, induction of AID expression by released factors and cytokines, such as 
Transforming Growth Factor (TGF)-β, APRIL, Retinoic Acid, interleukin (IL)-6 or IL-10 [52, 
54], renders IgA CSR potentially independent by T cell. This is the case for IgAs to 
commensal bacteria, whose release may be T cell-independent and necessitate direct 
interaction of dendritic cell (DCs) with B cells [55, 56].  
Macpherson et al. showed indeed that DCs in the dome of PPs are able to sample the 
commensal flora and convey live bacteria to the draining mesenteric lymphnodes, where 
they induce T cell - independent IgA production by B cells [55]. This process allows the 
containment of the bacteria to the MLNs which act as a sort of “firewall” and prevent 
bacterial dissemination through the lymphatic and blood systems. Neverthelss, induced 
IgA+ B cells can recirculate through the mucosal tissues and home back to the gut as the 
result of their expression of gut homing-receptors [57].       
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Figure 5-2 T cell-dependent and -independent mechanisms of Class-Switch Recombination 
in B cells. IgA class-switch recombination can be initiated through T cell-dependent or -
independent pathways. The former is due to CD40-CD40L interaction between T and B cells and 
lead to subsequent NF-κB pathway activation. NF-κB pathway can be alternatively engaged by 
factors secreted by ECs, such as BAFF and APRIL, independently of T cells. Besides, TSLP 
secreted by IECs acts on dendritic cells which start producing BAFF themselves.   
 
The role of IgAs in the control of intestinal microflora has been investigated through a 
number of different approaches; in general, the lack of IgAs usually results in the alteration 
of the commensal relationship between the intestinal microflora and its host.  
To evaluate the effect of single components on this process, Peterson et al. took 
advantage of germ-free RAG1-/- mice monocolonized with B. thetaiotamicron implanted 
with a hybridoma releasing monoclonal IgAs specific for a bacterium’s capsular 
polysaccharide [58]. In the absence of IgAs (i.e. mice without hybridoma), a potent innate 
immune response - exemplified by iNOS upregulation - is induced at the intestinal level 
and vice versa the bacterium needs to express enzymes required for the metabolism of 
host oxidative products. On the other hand, IgA production brings back the balance 
between host immune system and gut flora to the equilibrium, normalizing cytokine 
secretion.    
Moreover, mice which are knockout for Aicda and lack IgAs display an expansion of 
anaerobic bacteria, SFB among the others, which leads to the systemic hyperactivation of 
germinal center B cells [59, 60]. To dissect single contribution of CSR and SHM to this 
process, mice with point mutation in AID (AIDG23S mutant) were generated [61]. These 
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mice, which are characterized by normal CSR but defective SHM, show expansion of both 
aerobic and anaerobic bacteria in the feces and increased systemic dissemination of Y. 
Enterocolitica, though the effects being milder than the AID-/- mice. This suggests that 
diversification of the IgA repertoire through SHM, which has to shown to be dependent on 
the gut flora, T cells and Rorγt transcription factor [62], is necessary for the preservation of 
the host - microbes mutualism and for mucosal protection.   
 
5.2 Oral tolerance 
 
The general term “tolerance” refers to a series of mechanisms which take place in order to 
prevent the activation of the immune system to an antigen. It exists in three forms: central, 
peripheral and acquired.       
The first line of selection occurs in the primary lymphoid organs, i.e. the thymus and the 
bone marrow, where newly developing T and B cells, respectively, are deleted before the 
completion of their maturation in case they recognize self antigens [63]. T cells 
recognizing self antigen with high affinity can alternatively be induced to anergy or start to 
express the transcription factor Forkead Box P3 (Foxp3) and become natural Tregs.  
When mature lymphocytes reach the periphery, additional mechanisms contribute to the 
maintenance of tolerance as a lifeline toward T and B cell clones which recognize self 
antigens with low affinity or tissue-specific Ags that they have not encountered in primary 
lymphoid organs.     
Peripheral tolerance is mainly achieved by regulatory T cell - mediated suppression of 
autoreactive cells or by induction of hyporesponsiveness of lymphocytes which encounter 
antigens in the absence of co-stimulatory signals. In addition to this, autoreactive T cells 
may be negatively selected in the spleen or lymph nodes, or their recirculation may be 
impeded by anatomical barriers (as it is in the testes, brain and eyes) [64].  
As previously described, the gut represents the primary route by which the organisms are 
exposed to antigens in the periphery, including food Ags and microflora. The process by 
which tolerance to fed antigens is induced is generally known as oral tolerance. 
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Depending on the dose and frequency of administration of the antigen, peripheral 
tolerance is induced by anergy [65] or deletion of antigen-specific T cells [66, 67] for high 
dose Ags and induction of regulatory T cells after low and repeated Ag exposure [68], but 
these mechanisms are not exclusive.  
Tolerance in the gut is a complex process that requires the interaction of many factors and 
cell types. Specific subsets of APCs, particularly dendritic cells, are conditioned by the 
local environment and shape the nature of the tolerogenic response in the GALT. The 
main sites where oral tolerance is induced are the intestinal lamina propria, where DCs are 
loaded with the antigens, and the draining mesenteric lymph nodes, where migratory DCs 
induce the differentiation of Foxp3+ T regulatory cells (defined as induced Tregs) and the 
expression of gut-homing receptors on T cells. Specific features of LP dendritic cells and 
macrophages that contribute to the establishment of tolerance will be described in 
Paragraphs 3.2.3 and 3.2.4.           
Whether other secondary lymphoid organs are involved in the establishment of tolerance 
is still a controversial topic. As regard the role of PPs, Fujashi et al. showed that oral 
tolerance to proteins is not induced in PP-null mice, generated by the treatment of 
pregnant mothers with LT-β fusion protein, but still tolerance to haptens is maintained [69]. 
On the other hand, surgical resection of Peyer’s Patches in rats do not alter oral tolerance 
establishment [70]. The same ambiguous role is assigned to B cells that are the main 
immune components in the PPs, as either normal [71, 72] or defective [73] establishment 
of oral tolerance has been reported for B-cell deficient µMT or B-cell depleted mice.          
In addition to DC-mediated transport of antigens to MLN through the lymphatics, Ags may 
be drained in the bloodstream and reach the liver via the portal vein. Surgical alteration in 
the blood delivery to the liver has been shown, indeed, to impair oral tolerance in rats [74]. 
There, plasmacytoid DCs have a primary role in oral tolerance to haptens, based on a 
mechanism that depends on anergy / depletion of Ag-specific CD8+ T cells [75].           
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5.2.1 Dendritic cells: General overview 
 
Immature dendritic cells are found in almost all peripheral tissues where they capture and 
process foreign and self-antigens. Despite the lack of antigen-specific receptors that 
characterize the adaptive compartment of the immune system, DCs express non-clonally 
distributed receptors that allow their activation upon the encounter of foreign antigens or 
microbial products. This activation occurs through the recognition of phylogenetically 
conserved PAMPs expressed by microorganisms, through PRRs, such as C-type lectins, 
mannose receptors and Toll-like receptors [76]. TLR engagement favors the phagocytosis 
by DCs and induces the production of chemokines and cytokines that contribute to the 
initiation of the immune response and affect the nature of the subsequent adaptive 
response.  
As a result of their ability to sense infections and present antigens to T cells, DCs are often 
regarded to the link between the innate and adaptive immune system. However, they are 
not only involved in the initiation of primary immune responses, but also actively shape T 
cell-mediated responses and take part to the establishment of immunological tolerance 
[77].  
At steady state, DC migratory properties are essential for the distinction between non-
lymphoid tissue migratory DCs and lymphoid-tissue resident DCs.   
Migratory DCs carry out a sentinel function, as they patrol peripheral tissues, e.g. the skin 
and the mucosal surfaces, they sample Ags and via the lymphatics they migrate to the 
draining lymph nodes where they present the acquired antigens. Langerhans cells, dermal 
DCs and intestinal DCs are typical examples of migratory cells. 
Spleen- and thymus- resident conventional DCs are of non-migratory type and develop in 
situ from precursors arriving from the blood [78]. Indeed, it is now generally accepted that 
lymphoid tissue cDCs derive from pre-DCs via the common DC precursor (CDP) and 
Macrophage-DC precursor (MDP) [79, 80] (Figure 5-3).  
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Figure 5-3 Differentiation of Dendritic cells and Macrophages in mice. In the bone marrow, 
hematopoietic stem cells (HSCs) give rise to lymphoid (LPs) and myeloid progenitor (MPs) cells. 
MPs further differentiate into Macrophage-Dendritic Cell Precursors (MDPs) which may potentially 
give rise Monocytes and Common Dendritic cell Precursors (CDPs). From CDPs, pre-DCs 
(precursors of cDCs in the tissues) and PDCs (Plasmacytoid Dendritic Cells) are originated. Ly6C
+
 
monocytes may generate different cellular type, depending whether they seed steady-state or 
inflamed tissues. 
 
MDP, defined as Lin- cKithigh CD115+ CX3CR1
+ Flt3+, originates from bone-marrow 
progenitors with myeloid-restricted differentiation potential. Technical advances regarding 
the possibility to sort and re-transplant progenitor cells into recipient mice have allowed 
the definition of their developmental relationship, being MP (Myeloid Progenitors) > MDP 
> CDP > pre-DCs > cDCs. CDPs lose the ability to give rise to monocytes, which instead 
originate tissue macrophages and CX3CR1
+ cells in the intestine [80].        
DCs present in the tissues and lymphoid organs at steady state are often classified 
according to cell surface receptor expression. Conventional DCs in the spleen an lymph 
nodes express high levels of CD11c and three main subsets can be recognized according 
to their expression of CD4, CD8α and CD11b, namely CD4+ CD8α- CD11b+, CD8α+ CD4- 
CD11b-, and CD4- CD8α- CD11b+. CD8α+ DCs are specialized in MHC class I 
presentation, whereas CD4+ DC subset is specialized in MHC class II presentation. Unlike 
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CD4+ DCs, CD8α
+ DCs have also been shown to cross-present cell-associated antigens 
[81].  
    
5.2.2 GALT Dendritic Cells 
 
The intestinal immune system, generally referred as GALT (Gut-Associated Lymphoid 
Tissue), is usually distinguished in effector sites, consisting of lymphocytes residing in the 
intestinal epithelium and in the lamina propria, and organized tissues, that are responsible 
for the induction of the immune response, namely the Peyer’s patches, the isolated 
lymphoid follicles and the mesenteric lymph nodes (MLNs) [82] (Figure 5-4).   
 
Figure 5-4 Anatomy of the immune system in the intestine. Effector sites (sparse lymphocytes 
in the epithelium and lamina propria) and inductive site (Peyer’s Patches, Isolated Lymphoid 
Follicles and Mesenteric Lymph Nodes) are recognized.    
 
Peyer’s Patches (PPs) consist of B cell areas forming extensively follicular structures 
interspersed by inter-follicular regions, where T cells reside [83]. The overlying epithelium, 
known as follicle-associated epithelium (FAE), includes specialized microfold (M) cells 
which are unable to present antigens directly – since they do not express the major 
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histocompatibility complex (MHC) class II – but rather they transport Ags through the 
epithelial layer to APCs beneath. M cells have been also observed in the absorptive 
epithelium [84], but their low number can hardly account for this required mechanism. 
One of the most important features of immune regulation in the intestine is the presence 
of distinctive subsets of DCs in most part of the GALT. Despite this diversity, it has not 
been clarified yet whether certain subtypes may be specialized to drive different types of 
responses [85] or whether dendritic cells in general are able to integrate differential 
signals coming from the environment and modulate the subsequent response [86]. 
In murine PPs, at least four subtypes of CD11c+ cells have been described, according to 
their expression of CD11b and CD8α surface markers: CD11b+ CD8α-, CD11b- CD8α+, 
CD11b- CD8α- subtypes. An additional population of CD11cint CD8α+ B220+ plasmacytoid 
dendritic cells is also present at these sites [87].  
These cell types have specialized functions: CD11b+ CD8α- CCR6+ DCs are located in the 
subepithelial dome (SED) and activate primarily IL-10 - producing Th2 cells; CD11b- 
CD8α+ CCR6- DCs are localized in the T cell interfollicular regions (IFRs) and activate Th1-
type of responses; CD11b- CD8α- CCR6+ cells are located both in the SED and in the 
IFRs, can activate Th1-type responses [88] and migrate to the FAE following Salmonella 
infection [89].  
In the small intestine, different subtypes of DCs have been described, resembling the 
ones isolated from the Peyer’s Patches. Recently, a coherent phenotypical 
characterization of lamina propria cells has been obtained on the basis of their expression 
of CX3CR1 and CD103 markers [90, 91], defining two not-overlapping subsets of dendritic 
cells and macrophages that differ for their origin, function and turnover rate. These 
subsets of LP cells will be described in Paragraph 3.2.3 and 3.2.4. 
LP dendritic cells stand out for their immunomodulatory phenotype, since they express 
constitutively higher levels of interleukin (IL)-10 and interferon (IFN)-β than DCs from PPs 
or the spleen and show low expression of co-stimulatory markers on their surface, such as 
CD40, CD80 and CD86 [92]. Besides, a low amount of the pro-inflammatory cytokine IL-
12 is always observed, even upon LPS treatment in vitro. Similarly, dendritic cells isolated 
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from the colon are found in an immature state and produce constitutively IL-10, whose 
expression is upregulated after Toll-like receptors engagement [93, 94].  
Once dendritic cells in the lamina propria or in the PPs have phagocytised antigens, they 
transport them to the mesenteric lymph nodes where they prime naïve T cell. Upon first-
time encounter of an antigen, T cell response is characterized by the activation and clonal 
expansion of antigen-specific T cells. If the activation occurs in inflammatory conditions, T 
cells will continue to proliferate and establish a protective immune response.  
On the other hand, at steady state, DCs that have sampled dietary, self or commensal 
bacteria antigens migrate to the MLNs in the absence of any infection or inflammatory 
stimulus. This mechanism seems to accomplish for the induction of tolerance to ingested 
or innocuous antigens, since T cells expanded under tolerogenic circumstances fail to 
gain classical effector functions [95]. Expression of the chemokine receptor CCR7 by DCs 
appears to be critical for their migration to MLNs [95, 96].   
 
5.2.3 Lamina propria CD103+ Dendritic cells 
 
CD103 (also called integrin αE) has been associated with a subset of bona fide LP-DCs 
which derives from pre-DCs via the CDP and MDP and relies on Flt-3 ligand and GM-CSF 
for its development [79, 90, 91, 97].   
The best characterized ligand for CD103, E-cadherin, is mainly expressed by epithelial 
cells in the lamina propria [98], thus suggesting a possible mechanism by which CD103-
expressing cells (including DCs and CD8
+ T cells) might be kept in the tissue.  
GALT CD103+ DCs are endowed with tolerogenic functions contributing to the 
maintenance of intestinal tolerance [3, 99]. Indeed, they are able to induce the expression 
of gut homing molecules, such as CCR9 and α4β7, on T lymphocytes, both in humans and 
mice, [100-102] and to drive the peripheral generation of Foxp3+ T regulatory cells [103, 
104], through a mechanism that depends on TGF-β and Retinoic Acid.  
These soluble mediators are abundantly present in the intestinal tissues. For instance, 
epithelial cells [35, 105], stromal cells [54] and T regulatory cells in the GALT are major 
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producers of TGF-β. Usually, this cytokine is secreted in a latent inactive form, which 
needs the activation by several molecules, including MMP-9 and MMP-13, integrins (αvβ8), 
or thrombospondin-1.  
Besides, CD103+ dendritic cells are able themselves to produce TGF-β as they express 
tgfb2 gene and other enzymes needed for the correct localization and release of latent 
TGF-β [104]. CD103+ DCs express integrin αvβ8, as well [106, 107], and efficiently convert 
inactive TGF-β into its active form.  
Retinoic Acid derives from dietary vitamin A, which is sequentially metabolized by two 
enzymes, namely ALDH and RALDH. The former catalyzes the oxidation of vitamin A to 
retinaldehyde, the latter oxidizes retinaldehyde to retinoic acid. These enzymes are 
expressed by GALT CD103+ DCs, particularly the RALDH2 isoform [97], and by stromal 
cells in the mesenteric lymph nodes, which mainly express the RALDH-1 and -3 isoforms 
[108, 109].  
Vitamin A, introduced through the diet, is mostly stored in the liver and conveyed by the 
bile directly to the small intestine. There, it conditions CD103+ DC tolerogenic properties, 
including aldh1a2 expression and the induction of gut-homing receptors on T cells [110].         
The ability of CD103+ DCs to induce T regulatory cells is additionally dependent on their 
expression of IDO [111], an enzyme involved in tryptophan catabolism. IDO inhibition in 
vivo affects the establishment of tolerance to fed ovalbumin and exacerbates the outcome 
in two models of colitis (T cell-mediated and dextran sodium sulphate models - induced), 
thus providing further evidence for the tolerogenic role of these cells.           
CD103+ DCs in the lamina propria represent a heterogeneous population, further 
subdivided by the expression of CD8α and CD11b, in addition to CD11c and MHC-II as 
markers of conventional DCs. Thus, CD103
+ DCs have been divided into two main 
subsets, one CD8αhigh CD11bneg and one CD8αneg CD11bhigh [112].  
CD8αhigh CD11bneg cells mainly accumulate in the Peyer’s Patches and in the Isolated 
Lymphoid Follicles [91]. Despite this first report, CD8α+ DCs have been found in the 
intestinal lymph collected from mesenteric lymphoadenectomized mice by thoracic duct 
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cannulation [113]. in fact, Cerovic at al. showed that this DC subset is still present in 
Rorγt-deficient mice which lack PPs and ILFs.    
CD8αhigh CD11bneg cells depend on Id2 and IRF8 transcription factors for their 
development [91, 114]. Moreover, in the lamina propria these cells are almost uniformly 
marked by the expression of the chemokine receptor XCR1 and are absent in Batf3-
deficient mice [115, 116]. As CD8α+ cDCs in the lymphoid organs, they are endowed with 
superior ability of cross-presentation of cell-associated antigens [117].      
The CD8αneg CD11bhigh subset expresses aldhh1a2 and Toll-like Receptors -5 and -9. In 
response to flagellin, this subset induces the T cell-independent differentiation of naïve B 
cells to IgA+ B cells and the polarization of T cells to Th1 and Th17 phenotype [112, 118].  
CD103+ DCs are usually considered a migratory population, as they express CCR7 [91] 
and are found in the MLN-afferent lymph [97]. Although the migration occurs at steady 
state, it can be further increased by TLR stimulation. Accordingly, after oral infection with 
S. Thyphimurium, CD11b+ CD103+ DCs are the only DCs in the draining MLNs bearing 
GFP-labeled Salmonella [91].  
In the absence of CCR7, mice have reduced CD11b+ CD103+ DCs in the MLN [91] and do 
not develop tolerance to fed antigens [95]. Hence, not only these cells are gifted with 
tolerogenic properties, but antigen transport to the MLN seems to be essential for the 
establishment of oral tolerance [95]. However, CD103+ DCs are not highly phagocytic by 
themselves [97], hence they might acquire antigens from other cells, possibly the CD103- 
counterpart or epithelial cells. As recently described by McDole et al., goblet cells may 
possibly bridge dextran and low-molecular weight soluble antigens to CD103+ DCs in the 
lamina propria [119].              
The tolerogenic features of CD103+ DCs are not preserved under inflammatory conditions, 
but these cells are turned into a pro-inflammatory state. For instance, in a model of T-cell 
transfer colitis, CD103+ DCs sorted from the mesenteric lymphnodes show lower 
expression of aldh1a2 and tgfb2 genes and reduced ability to induce Foxp3+ Treg cells. 
Conversely, they polarize T cells to Th1 phenotype, similarly to the CD103- counterpart 
[120].  
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Furthermore, CD11b+ CD103+ DCs provide a first line innate defense to bacterial infection.   
In response to flagellin stimulation, CD11b+ CD103+ DCs isolated from the SI secretes 
pro-inflammatory cytokines, such as IL-12p40 and IL-23p19 [121], and mediates AMP 
secretion by epithelial cell via a mechanism that depend on IL-22.   
 
5.2.4 CX3CR1 lamina propria cells 
 
CX3C Chemokine Receptor 1 (CX3CR1), also known as Fractalkine receptor, is mainly 
involved in leukocyte adhesion and migration. Its main ligand, Fractalkine or CX3CL1, is 
mostly expressed by epithelial and endothelial cells in the intestine in a membrane-
anchored form, which can be cleaved by metalloproteases to generate a soluble 
chemokine with chemoattractive properties [122, 123].  
The expression of the fractalkine receptor CX3CR1 has been for a long time associated 
with a subset of lamina propria dendritic cells capable of forming trans-epithelial 
projections, of capturing luminal bacteria, such as invasion-defective Salmonella enterica 
[124-127] and even of transmigrating to the gut lumen in a MyD88-mediated fashion [128].  
Lumen sampling by CX3CR1
+ cells depends on the expression of the Fractalkine receptor 
and requires the formation tight junction (TJ)-like structures within intestinal epithelial cells 
through the expression of TJ proteins, such as occludins and claudins. Experiments 
performed with bone marrow chimeras highlighted the role of the epithelium in mediating 
DC extensions [126]. The mechanism is MyD88-dependent and is probably due to the 
release by ECs of chemokines and chemical mediators, such as CCL20 (MIP-3α), which 
recruit cells via CCR6 receptor.   
Phenotypical and functional characterization of CX3CR1
+ cells have challenged the initial 
definition of these cells as DCs, as they share common features with macrophages [129].  
Indeed, the lack of specific markers which univocally classify DCs and macrophages in 
the non-lymphoid organs has raised a heated debate about the definition of the identity of 
these cells. It is now generally accepted that in non-lymphoid organs CX3CR1 expression 
marks a subpopulation of LP-resident Mϕ, which derives from Ly6Chigh blood monocytes 
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and depends on Macrophage Colony Stimulating Factor (M-CSF) for its development [90, 
91]. At steady state, they can be phenotipically distinguished as F4/80+ MHC-II+ CX3CR1
+ 
CD103- CD11b+ cells, and some share with cDCs the expression of integrin αx, known as 
CD11c [117, 129, 130].  
However, not all CX3CR1
+ cells can be called macrophages, as recently Cerovic et al. 
found a population of CX3CR1
int cells in the lymph collected from the thoracic duct in mice 
undergone mesenteric lymphadenectomy. These cells resemble CD103+ DCs, as they are 
migratory, prime efficiently T cells and respond to Flt3 [113], but differently from CD103+ 
LP cells they polarize T cells to Th1 and Th17 phenotype.   
CX3CR1
+ Mϕ are highly phagocytic and accumulate in response to microbiota-derived 
signals [131], as they are reduced in the small and large intestine of germ-free mice. They 
poorly prime naïve T cells, but preferentially support Th1 / Th17 T cell differentiation [131]. 
Even commensal-derived products, such as ATP, can favor Th17 response mediated by 
CD70high CX3CR1
+ cells [132].     
F4/80+ CX3CR1
high macrophages produce high levels of IL-10 and acquire an anti- 
inflammatory phenotype when stimulated with LPS [117, 133]. IL-10 has been linked to 
secondary Treg cell expansion in the intestinal mucosa after their generation in the MLNs, 
pointing out a role for CX3CR1
+ cells in oral tolerance establishment. Mice lacking the 
expression of functional CX3CR1 receptor, where production of IL-10 by these cells is 
abolished, fail indeed to develop tolerance to fed ovalbumin and to accumulate Tregs in 
the intestinal lamina propria [134].  
Besides, also F4/80 knockout mice are not tolerized after Ag feeding, but in this case the 
underlying mechanism seems to be the defective generation of CD8+ T regulatory cells 
[135].      
In inflammatory conditions, Ly6Chigh monocytes give rise to E-cadherin+ F4/80int CX3CR1
int 
CD11b+ macrophages that secrete pro-inflammatory cytokines, such as IL-12, IL-23 and 
TNF-α [117, 136]. A similar population of inflammatory macrophages, expressing TLR-2 
and -4 and low to intermediate levels of CX3CR1 has been described to accumulate in the 
inflamed colon in a model of DSS colitis [137]. 
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Ly6Chigh monocyte recruitment to the inflamed tissue depends on their expression of 
diverse receptor, such as CCR2 and CX3CR1. Accordingly, CCR2 - and CX3CR1 - deficient 
mice are less susceptible to experimental colitis after DSS treatment [137, 138] or in a T-
cell mediated model [131], respectively, consistently with impaired recruitment of 
inflammatory precursors.     
 
5.2.5 T Regulatory cells 
 
It is now generally accepted that mucosal antigen administration induces the development 
of T regulatory cells that are fundamental for the establishment of oral tolerance. Treg 
cells comprise several subsets of both CD4+ and CD8+ T cells, which control and 
suppress effector immune responses. Based on their origin, two main subsets of Treg 
cells have been described: naturally occurring CD4+CD25+ regulatory T cells (nTregs), 
which develop in the thymus and suppress self-reactive T cells in the periphery, and 
inducible regulatory T cells (iTregs), which arise in the periphery from naïve T cells, after 
being in contact with regulatory cytokines and / or APCs.  
Indeed, generation of Tregs outside the thymus is often based on T cell activation in the 
absence of inflammation, a situation generally referred as sub-immunogenic, which may 
be achieved by antigen presentation in the absence of co-stimulatory signals or in specific 
“tolerogenic-prone” environments, such as the gut mucosa. 
Despite the different origin, it is a hard task to discriminate between nTregs and iTregs, as 
they share common markers, and to understand how they singularly participate to the 
maintenance of peripheral tolerance. Transcriptional profiling of in vitro induced iTregs and 
in vivo isolated nTregs has led to the identification of differential expressed genes, which 
contribute to the definition of the genetic signature of the two populations [139]. Among 
them, Ikzf2 (Helios) and Nrp1 (Neuropilin-1) are preferentially expressed by nTregs.. The 
transcription factor Helios was indeed proposed as a marker of thymic T regulatory cells 
[140], but more recently it has been shown to be expressed also by iTregs, depending on 
the conditions of activation [141]. Recent reports have, instead, confirmed higher 
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expression of Nrp1 in nTregs compared to Foxp3
+ iTregs isolated from MLNs or the spleen 
[142, 143].        
In order to functionally dissect single contribution of nTregs and iTregs to peripheral 
tolerance, mice lacking nTregs where generated crossing TCR-transgenic mice to RAG - 
deficient mice. These mice have normal naïve B and T cells, are devoid of nTregs and 
develop an allergic disease after immunization with Hemagglutinin (HA) Ag as they bear 
HA-specific monoclonal B cells [144]. Interestingly, oral tolerance is efficiently established 
in the absence of thymus-derived T cells; besides, iTregs can be peripherally generated 
after antigen feeding and display suppressive activity in vivo and in vitro. 
Inducible regulatory T cells have been classified into IL-10 producing T regulatory 1 (Tr1) 
cells, TGF-β secreting T helper 3 (Th3) cells and converted Foxp3+ Regulatory T cells.    
Tr1 may be generated in vitro and in vivo after priming in the presence of IL-10 [145]. Tr1 
cells are characterized by the production of IL-10 and lack of Foxp3 expression [146]; in a 
model of H. hepaticus-induced colitis in RAG2-/- mice reconstituted with CD4+ CD45RBhigh 
T cells, Tr1 cells actively suppress the intestinal pathology through an IL-10 - and TGF-β -  
dependent mechanism [147]. Besides, also expression of CTLA-4 by Tr1 cells contributes 
to their suppressive function and ability to control intestinal inflammation [148].  
Th3 cells are characterized by the ability to produce TGF-β and have been initially 
described during oral tolerance induction [68]. Their suppressive properties and ability to 
secrete TGF-β are common features that Th3 cells share with Foxp3+ Regulatory T cells; 
unfortunately, most of the characterization of Th3 cells has been performed before the 
introduction of Foxp3 as a marker of T Regulatory cells, hence they might represent the 
same population. 
Among iTregs, Foxp3
+ Tregs have been in the last years the most attractive as they have 
been shown to be directly involved in oral tolerance establishment [134]. Phenotypically, 
they are defined as CD4+ CD25+ Foxp3+; they develop in vitro from naïve CD4+ Foxp3- T 
cells upon the interaction with certain subsets of DCs, or in vivo after oral antigen 
administration [103, 104] or after Ag-targeting to DEC205+ cells [149]. Particularly, in 
experiments performed with RAG-1-/- mice adoptively transferred with TCR-specific 
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congenic naïve T cells, after Ag feeding Foxp3+ Treg cell conversion takes place 
preferentially in the GALT, mainly MLNs and LP [103]. Hence, various environmental 
factors seem to influence the development of Foxp3+  Tregs in vivo; minimal requirements 
for this process are represented by TGF-β and IL-2, both in vivo and in vitro [150].     
Once generated, iTregs home back to the intestinal lamina propria, where they are re- 
stimulated and expanded by IL-10 - producing CX3CR1
+ Mϕ [134]. The correct homing of 
Foxp3+ Tregs depends on their expression of gut-homing receptors, such as α4β7 or 
CCR9. Accordingly, β7 - [134] and CCR9 [151] - deficient mice do not develop oral 
tolerance; this phenotype is definitely corrected after WT T cell transplantation. 
 
5.3 Gap Junctions 
 
5.3.1 Structure and Function 
 
In a physiological environment, tissue integrity and homeostasis are preserved by the 
balanced response of cells to signals coming from the extracellular matrix, soluble 
mediators and other cells. In particular, communication among adjacent cells is mediated 
by adhesion complexes, such as adherens, tight and gap junctions (GJs) [152]. Adherens 
and tight junctions mainly control paracellular permeability and polarity, while GJs allow 
direct communication between cells. Indeed, small peptides, secondary messengers and 
metabolites may be transferred through GJs, contributing to electrical and biochemical 
coupling of cells.     
GJs consist of hemichannels (known as connexons) that, when juxtaposed, form channels 
between two adjacent cells. Each hemichannel represents a complex of six connexin 
proteins, which share a common structure. In fact, connexins (Cxs) are made of nine 
domains: the N-terminus, two extracellular loops and four transmembrane domains, which 
are highly conserved; a cytoplasmic loop and the C-terminus, which vary in length and 
sequence and specifically mediate the biological functions of Cxs.  
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The cytoplasmic tail and loop can be post-translationally modified, especially by 
phosphorylation, which is relevant for the GJ assembly and the modulation of its 
physiological functions [153]. Besides, the C-terminus interacts with cytoskeletal elements 
and intracellular proteins, such as kinases, phosphatases, membrane receptors and cell 
signaling proteins, which highlight the role for gap junctions also in intracellular signaling, 
in addition to cell-cell communication [152].                     
Furthermore, hemichannels can form non-junctional channels in unopposed areas of the 
cell membrane, causing the release of a variety of factors such as ATP, glutamate, and 
NAD+ into the extracellular space, especially under mechanical or ischemic stress [154].  
Twenty-one Cx genes have been identified in humans, twenty in mice; their expression is 
tightly regulated during development and in a tissue-specific manner. Among them, only 
Cx43 is ubiquitously expressed; GJ formed by connexin 43 electrically couple heart 
muscle cells and control synchronous heart muscle contractions. Connexin 43-deficient 
mice show a plethora of defects and die postnatally as the result of ventricular arrhythmia 
[155]. 
 
5.3.2 Gap Junctions in the Immune System 
 
As already described, GJs mediate the passage of small molecules, such as ions, 
metabolites, second messengers and peptides, so that electric, metabolic and 
immunological pieces of information are diffused.   
The first two have been extensively characterized in nervous cells of the brain and in 
cardiac cells; however, the role of GJs in the immune system remain elusive and only few 
studies have been reported until now.     
Immune cells express a defined panel of connexins [156], such as Cx43 and more rarely 
Cx40, Cx37 and Cx32, as shown in Table 1, and through GJs they are coupled to other 
immune cells or endothelial and stromal cells [157, 158].  
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Table 1 Connexin expression in cells of the immune system (from Neijssen et al., 2007) 
 
Immune cells in the bone marrow communicate with stromal cells mainly via Cx43. Cx43 
deficient fetuses at embryonic day 14.5 show reduced progenitor cells in the liver, 
suggesting a role for Cx43 in stem cell development [159]. In addition to this, Cx43-/- mice 
show defects in T and B lymphopoiesis [160]. 
Connexin 
isotype 
Cell types Function Coupled cell types References 
Cx43 
Bone marrow 
derived DC 
Cross-
presentation 
Bone Marrow DCs -
Tissue cells 
Neijssen et al. (2005) 
  
DC activation 
Bone Marrow DC - 
Bone Marrow DC 
Matsue et al. (2006) 
 
Bone marrow 
stromal cells 
Haematopoiesis 
Bone marrow 
stromal cells - HSCs 
Cancelas et al. (2000) 
 
Haematopoietic 
stem cells    
 
Follicular DC 
Germinal centre 
development 
Follicular DCs - B 
cells 
Krenacs et al. (1997) 
   
Follicular DCs - 
Follicular DCs  
 
Monocytes 
Cross-
presentation 
Monocytes - Tissue 
cells 
Eugenin et al. (2003) and 
Neijssen et al. (2005) 
 
Tonsil DC 
 
DCs - Tissue cells 
 
 
Appendix DC 
 
Langerhans cells - 
Tissue cells  
 
Langerhans cells 
   
 
Macrophages Inflammation 
Macrophages - 
Intestinal 
endothelium 
Martin et al. (1998) 
 
Thymus epithelial 
cells 
T cell 
development 
TEC - T cell 
progenitor cells 
Alves et al. (1995) and 
Fonseca et al. (2004) 
 
T cell progenitors 
   
 
T cells Maturation (?) T cells - T cells Oviedo-Orta et al. (2000) 
 
B cells 
Antibody 
secretion 
T cells - B cells Oviedo-Orta et al. (2001) 
 
NK cells Activation (?) NK cells - NK cells Oviedo-Orta et al. (2000) 
 
Mast cells Unkown 
Mast cells - Mast 
cells 
Vliagoftis et al. (1999) 
   
Mast cells - 
Fibroblasts  
 
Polymorphonucle
ar neutrophils 
(PMN) 
Extravasation PMN - PMN Jara et al. (1995) 
   
PMN - Endothelium Zahler et al. (2003) 
Cx40 T cells Maturation (?) T cells - T cells Oviedo-Orta et al. (2002) 
 
B cells 
Immunoglobulin 
secretion 
T cells - B cells 
 
   
B cells - B cells 
 
Cx37 Macrophages Atherogenesis 
Macrophages - 
Smooth muscle cells 
Kwak et al. (2002) 
 
Monocytes 
Prevention of 
atherosclerosis 
Hemi-channel Wong et al. (2006) 
Cx32 Mast cells Unknown 
Mast cells - Mast 
cells 
Vliagoftis et al. (1999) 
   
Mast cells - 
Surrounding cells  
Cx30.3 Thymocytes Unknown - Fonseca et al. (2004) 
36 
 
Few findings about the expression of connexins by dendritic cells have been reported. For 
example, follicular DCs upregulate Cx43 expression and form GJs among each other or 
with B cells in the germinal center upon antigen challenge [161].  
Also bone marrow-derived dendritic cells form GJs in vitro, especially after stimulation of 
cells with LPS or IFN-γ. Inhibition of GJ formation dampens the activation of BM-DCs, 
measured as CD40 expression [162]. In addition to this, Neijssen et al. have 
demonstrated that activated human monocytes are able to take up antigenic peptides 
through GJs from a peptide-expressing cell line and cross-present them to Ag-specific 
cytotoxic T cells [163]. Peptides need to fulfill some requirement in order to be transferred 
through GJs and subsequently presented on MHC-I, that is to be around 9 amino acids in 
length (about 1 kDa). Thus, GJs couple the antigen processing machinery of adjacent 
cells, sustaining cross-presentation.  
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6 Aim of the project 
 
The role of GALT mononuclear cells in the establishment of oral tolerance has been 
extensively investigated in the past years and linked to peculiar functional determinants of 
these cells. In particular, while one subset of mononuclear cells is apt at antigen capture, 
another one is mostly involved in T cell priming towards a tolerogenic phenotype. In this 
thesis, our aim was to understand fine mechanisms underlying the phase of antigen 
uptake in the small intestine, as well as mechanisms of cooperation between the different 
mononuclear phagocytes, as the initial steps in the induction of oral tolerance to 
intragastrically-delivered antigens. 
Hence, we are proceeding through these steps: 
• Characterization of the SI cell subsets involved in antigen uptake, mostly focusing 
on LP subsets of CX3CR1
+ macrophages and CD103+ dendritic cells;   
• Evaluation of the effects of CX3CR1 deficiency on Ag uptake and oral tolerance 
establishment; 
• Assessment of the possible transfer of antigens among lamina propria cells, 
through gap junctions, and its effect on the induction of tolerance to fed antigens. 
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7 Materials and Methods 
 
7.1 Mice 
 
6-7 weeks old female C57BL/6J mice were purchased from Charles River. CX3CR1
GFP/GFP 
(B6.129P-Cx3cr1tm1Litt/J), Cx43fl/fl mice (B6.129S7-Gja1tm1Dlg/J) and CD11c-CRE mice 
(B6.Cg-Tg(Itgax-cre)1-1Reiz/J) were purchased by Jackson Laboratory. Animals were 
bred and maintained in our SPF (Specific Pathogen Free) animal facility. Cx43fl/fl mice and 
CD11c-CRE were genotyped after tail biopsies, following the protocol recommended by 
Jackon Laboratory. Tails were lysed and genomic DNA extracted.  
Standard PCR was performed using the following primers: 
Cx43 Forward CTTTGACTCTGATTACAGAGCTTAA 
Cx43 Reverse GTCTCACTGTTACTTAACAGCTTGA 
CD11c-CRE Forward ACTTGGCAGCTGTCTCCAAG 
CD11c-CRE Reverse GCGAACATCTTCAGGTTCTG 
All experiments were performed in accordance with the guidelines established in the 
Principles of Laboratory Animal Care (directive 86/609/EEC).  
 
7.2 Tolerance Induction by intragastric Antigen Delivery 
 
Mice were fed with 1 or 20 mg of ovalbumin in 200 µl DPBS by gavage on days 13, 10 
and 7 before OVA/CFA immunization. Mice were immunized subcutaneously with 50 ug 
OVA in 100 ul PBS/CFA emulsion. After 7 days, mice were challenged by s.c. injection of 
250 µg heat-aggregated OVA in 20 µl of PBS in the left hind footpad. Right footpad 
received PBS as a control. OVA-specific DTH was determined by footpad swelling 24 and 
48 hours after challenge. 
Total splenocytes were subsequently isolated and re-stimulated in vitro with 1 mg/ml 
ovalbumin. In particular, spleens were collected and smashed onto a 70 µm cell strainer. 
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Red blood cells were lysed using a hypotonic red cell lysis buffer. 50000 cells per each 
well were seeded in a 96-well plate.  
After restimulation, supernatants were collected after 4 days and IFN-γ measured by 
ELISA using CBA FACSArray. 
 
7.3 Intestinal loop and ovalbumin administration 
 
CX3CR1
GFP/+ mice were anesthetized with 2.5% Avertin for the duration of the experiment. 
Segments of the small intestine were exposed and ligated at both extremities with surgical 
thread. 40 µg of ovalbumin-Alexa Fluor (AF) 647 (Molecular Probes) were injected into the 
loop, the intestines removed after two hours and processed for immunofluorescence 
staining.     
When indicated, 250 µg of ovalbumin-Alexa Fluor 647 were administered intra-gastrically 
in 200 µl DPBS using a feeding needle.  
 
7.4 Immunofluorescence staining  
 
Tissues were fixed in 0.1 M L-Lysine pH 7.4 and 1% paraformaldehyde in PBS for 12 
hours, dehydrated in 20% sucrose for 12 hours and frozen in OCT (Sakura Finetek). 10 
µm-thick sections were cut and posed on Poly-L-Lysine coated microscope slides. 
Sections were blocked in 1% Bovine Serum Albumin and 1% Triton X-100 and were 
subsequently stained using the following antibodies: α-CD11c (Clone HL3, BD 
Pharmingen), α-CD11b (Clone M1/70, conjugated with Pacific Blue, eBioscience) and α-
KbOVA (25-D1.16, eBioscience).  
α-KbOVA was conjugated with AF568-labeled Fab fragments using the Zenon Mouse IgG 
Labeling Kit (Molecular probes) according to manufacturer’s instruction. Sections were 
then extensively washed and incubated with secondary antibody against hamster anti-
CD11c, which is Cy3 Goat anti-Armenian Hamster IgG (Jackson ImmunoResearch). 
Phalloidin and DAPI were added when indicated. 
40 
 
Confocal images were collected with a Leica TCS-SP2 (Leica Microsystem) with a 40x or 
63x objectives and processed using Imaris 6.1.0. (Bitplane).  
 
7.5 Isolation of small intestine lamina propria cells 
 
Small Intestines were cut into small pieces and washed in separation medium (PBS, 1% 
fetal bovine serum, 1 mM DTT, 1 mM EDTA) for 15 min at 37°C. Tissues were 
subsequently incubated in digestion medium consisting of MEMα medium, 5% fetal bovine 
serum (FBS), 0.5 mg/ml collagenase type VIII (Sigma-Aldrich), 5 U/ml DNase I (Roche 
Diagnostics), 100 IU/ml penicillin and 100 µg/ml streptomycin for 30 min at 37°C by gentle 
shaking. Cells were passed through a mesh and centrifuged. Red blood cells were lysed 
with a hypotonic lysis buffer.   
For FACS staining or cell sorting, cells were incubated with anti-FcR antibody (clone 
24G2; BD Biosciences) and stained with the following primary antibodies: anti-CD45.2 
(clone 104, eBioscience), CD11c (clone HL3, BD Pharmingen), MHC-II (clone 
M5/114.15.2, eBioscience), CD103 (clone M290, BD Pharmingen), CD11b (clone M1/70, 
eBioscience), KbOVA (clone 25-D1.16, eBioscience), CD86 (clone GL1, BD Pharmingen), 
CD40 (clone HM40-3, BD Pharmingen) and CD83 (clone Michel-19, BD Pharmingen). 
DAPI was added to exclude dead cells.  
Samples were acquired using FACSCanto (BD Biosciences) and analyzed by FlowJo 
(Treestar).  
When indicated, MHC-II+ CD11c+ cells were sorted by FACSAria (BD Biosciences) into 
CD11b- CD103+, CD11b+ CD103+, CD11b+ CX3CR1
int
  and CD11b
+ CX3CR1
high populations.  
Collected cells were sorted in complete medium (RPMI, 10% FBS, 1%P/S, 1% Glutamine, 
50 µM β-Mercaptoethanol) and subsequently centrifuges at 2000 rpm for 10’. When 
proceeding with RNA extraction, cells were lysed in RTL Plus Buffer (Quiagen).     
For CD11c+ cell-enrichment, cells were incubated with anti-FcR antibody, then with anti-
CD11c MACS beads (Miltenyi Biotec) and purified according to manufacturer’s instruction. 
Briefly, cells were incubated with CD11c MicroBeads in MACS Buffer for 15 minutes at 
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4°C, washed and passed onto a MS Column (Miltenyi Biotec). To get a better purity, cells 
were passed twice onto the colums.   
 
7.6 Isolation and enrichment of CD11c+ from MLNs, spleen and PPs 
 
Murine MLNs, spleens and Peyer’s Patches were digested in RPMI-1640 containing 5% 
FBS, 1 mg/ml collagenase D and 5 U/ml DNase I (Roche) for 20 min at 37°C.  
Tissues were subsequently smashed and cell suspension centrifuged. Red blood cells 
were lysed with a hypotonic lysis buffer.  
Cells were incubated with anti-FcR antibody (clone 24G2; BD Biosciences), followed by 
anti-CD11c MACS beads enrichment (Miltenyi Biotec). In order to obtain a higher purity, 
cells were passed twice onto the column. 
 
7.7 Dye and Antigen Transfer Assays 
 
CD11c+ cells were enriched from small intestines of C57BL/6 mice (as previously 
described) and were divided into two pools: one was labeled with 15 µM DDAO (Molecular 
Probes) for 15 minutes at room temperature; the second was labeled with 0.5 µM Calcein-
AM (Molecular Probes) in serum-free medium for 30 minutes at 37°C. After labeling, cells 
were extensively washed in complete medium.   
The two pools were co-cultured for 30 minutes and calcein transfer was evaluated by 
FACS. When indicated, cells were pre-treated with 1-Heptanol (Sigma Aldrich), a gap 
junction inhibitor, at different concentration (0.5, 5 and 50 mM). 
For the experiment of Ag transfer, CD103+ DCs and CX3CR1
+ LPCs were sorted from 
CX3CR1
GFP/+ mice. They were respectively loaded with 100 µg ovalbumin-Alexa Fluor 647 
for 1 hours and then washed extensively. Sorted subpopulations were subsequently co-
cultured with the unlabelled counterpart for 1 hour and transfer of antigenic material was 
evaluated by FACS. 
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7.8 Staining for T regulatory cells 
 
Cells suspensions were prepared from the small intestine and mesenteric lymph nodes, 
as previously described. Cells were subsequently permeabilized using the eBioscence 
Fix/Perm buffer for 30’. They were subsequently stained in Wash/perm Buffer 
(eBioscience) with anti-CD45.2 (clone 104, eBioscience), CD3 (clone 17A2, BD 
Pharmingen), CD4 (clone H129.19, BD Pharmingen), CD8 (clone 53-6.7, BD 
Pharmingen), CD25 (clone 3C7, BD Pharmingen) and Foxp3 (clone FJK-16s, 
eBioscience). Samples were acquired with FACSCanto (BD Biosciences) and analyzed 
using FlowJo (Tristar).    
 
7.9 Quantitative RT- PCR analysis 
 
RNA was extracted using the RNeasy Micro Kit (Qiagen). RNA was reverse transcribed 
with random hexamers and SuperScript III reverse transcriptase (Invitrogen). Quantitative 
real-time RT-PCRs were performed with the SYBR Green PCR kit on the Applied 
Biosystems 7500 RT-PCR System (Applied Biosystems). Results were quantified using 
the 2-∆∆CT method [164]. The expression levels of the genes of interest were normalized to 
the expression levels of the reference Rlp32 gene. PCR experiments were performed in 
duplicate.  
Primers that were used are indicated in the following table: 
 
Gene Forward (5'-3') Reverse (5-3') 
Cx23 ATCAGTTCCGGCCAATAACTC ATCACAGTGTACACGGGCTTC 
Cx26 GCTTCAGACCTGCTCCTTACC GGTGGAGTGTTTGTTGACACC 
Cx29 AAGGACACAACCGATGAATTG TTGACTGCAAGCACCTTTACC 
Cx30 AAGCCCTGGAGAACAAGACTC CAAAGTCCTCCTGCTCATCAC 
Cx30.2 AGGACGAGCAGGAGGAGTTC AGGATGTGGAAGAGCCAGAAG 
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Cx30.3 CTTCCCTGTTAGTGGTCATGC CAGCAGCCTTGAAGATGAGAC 
Cx31 GACAACTTCTTCCCCATCTCC ACCAATTCGATGATGAGCTTG 
Cx31.1 TACGTCTTCAGCCTCTCGTTC CAGCTCCACAAGGTTAAGCAG 
Cx32 ACAGCCATTGGCCGAGTATG TGTTGGTGAGCTACGTGCATT 
Cx33 AGGAAGAACTGGAAGCTGCTC GCCATCTCGAAGACAGACTTG 
Cx36 TACTGCCCAGTCTTTGTCTGC TACACCGTCTCCCCTACAATG 
Cx39 TTGTTGGGATTCCTCATCATC ACTGGGGAAAAGAGGTCGTAG 
Cx40 AGAGCCTGAAGAAGCCAACTC CGGAAAATGAACAGGACAGTG 
Cx43 ACTTCAGCCTCCAAGGAGTTC GGAGTAGGCTTGGACCTTGTC 
Cx45 TTGGGAAAGCAACAAACAAAG ATCTCCTCTAGCAGGCGAGTC 
Cx46 GGCTGTGAGAACGTCTGCTAC CCGCTCTTTCTTCTTCTCCTC 
Cx47 AGCTCTGCCTTGTGCATCTC GGTGGAATGATTGTGGATCTC 
Cx50 GCAGCAAGAGAGAAAGACAGC ACAGTGGAGTGCTCATTCACC 
Cx57 AATTTACTGGGTGGCATCCTAGA GGGAAAGCATCATCGTAACAGAT 
Rlp32 AAGCGAAACTGGCGGAAAC TAACCGATGTTGGGCATCAG 
 
 
7.10 Evaluation of homologous recombination event at Cx43 locus in 
Cx43fl/fl CD11c-CRE mice 
 
CD11c+ cells were enriched from the small intestine of Cx43fl/fl CD11c-CRE+ mice and 
control mice (Cx43+/+ CD11c-CRE+, Cx43fl/fl CD11c-CRE-). They were subsequently lysed 
and genomic DNA was extracted using phenol-chloroform extraction. In order to evaluate 
deletion of exon 2 in Cx43 gene, standard PCR was performed using the following 
primers: 
YL49 (5’-3’) GCTACTTCTTGCTTTGACTCTGATTA 
YL50 (5’-3’) GCTCACTTGATAGTCCACTCTAAGC 
The PCR reaction amplifies a fragment of 686 bp when exon 2 is deleted.  
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7.11 Statistics 
 
Results were represented as Mean ± SEM or Mean ± SD (when indicated). Statistical 
significance was determined by the Student's t test using GraphPad Prism software. 
*p<0.05, **p<0.01, n.s. not significant. 
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8 Results 
 
8.1 Characterization of antigen uptake in CX3CR1
GFP/+ and 
CX3CR1
GFP/GFP mice  
 
8.1.1 CX3CR1
+ cells are responsible for antigen uptake in the small intestine 
 
Efficient induction of tolerance to food antigens relies on different processes, among 
which one of the main critical steps is represented by the ability of antigen presenting cells 
to uptake antigens in the lamina propria of the small intestine and to migrate through the 
lymphatics to the draining lymph nodes [95].   
In order to assess whether a defined subset of lamina propria cells was responsible for 
the uptake of soluble antigens, we took advantage of CX3CR1
GFP/+ knock-in mice [165], 
which bear in heterozygosis the gene coding for Green Fluorescent Protein (GFP) under 
the control of the CX3CR1 promoter. The use of this mouse model allows the efficient in 
vivo tracking of cells expressing CX3CR1, which marks in the small intestine a population 
of sessile cells, generally considered resident macrophages.        
Thus, CX3CR1
GFP/+ mice were subjected to intestinal ligation and a fluorescently-labeled 
protein, ovalbumin (OVA) conjugated with Alexa Fluor 647, was injected into the intestinal 
loop. After two hours, the loop was resected and tissues fixed and processed for imaging 
analysis.   
10 µm-thick sections were initially stained with phalloidin to evaluate general integrity of 
the tissue. As shown in Figure 8-1, intestinal surgery did not alter epithelial layer continuity 
as suggested by the uninterrupted actin staining of the IECs.   
As ovalbumin is fluorescently-labeled, it can be then visualized on the tissue sections; 
additional staining with anti-CD11c to localize DCs was performed.  
As depicted in Figure 8-2, Ag localization was restricted to CX3CR1
+ LP cells, preferentially 
to those positioned in the apical part of the villus. Indeed, a gradient of cells, which have 
 phagocytosed OVA, was highlighted going
may be expected considering antigen availability and accessibility in the intestinal lumen. 
Three-dimensional reconstruction of the villus (
AF647 was preferentially lo
cells present in the lamina propria.    
This initial observation was confirmed in a time course experiment, where OVA
was administered in a more physiological setting 
collected at different time points after feeding and were processed for FACS analysis, 
which allowed a quantification of the antigen uptake process that was observed by 
imaging techniques. Generally, CX
two main subsets of antigen presenting cells in the small intestine, namely CX
expressing Mϕ and CD103
     
Figure 8-1 Evaluation of tissue integrity and epit
CX3CR1
GFP/+
 mice was exposed and ligated to form a loop. The loop was injected with 40 
ovalbumin conjugated with Alexa Fluor 647. After 2 hours, the loop was resected and fi
Sections were stained 
C. Red, Actin (A); Blue, DAPI (
15 µm.  
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 from the apical to the basal part of the villi, as 
Figure 8-3) clearly showed that OVA
cated in the cytosol of CX3CR1
+ cells, but not in other CD11c
 
via the oral route. Small intestines were 
3CR1 and CD103 markers are used to discriminate the 
+ DCs.  
helial layer continuity.
with Phalloidin (A) and  DAPI (B). Single channels are shown in panel
B); Green, CX3CR1 (C). Merged images are shown in (
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+ 
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3CR1-
 
 The small intestine of 
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D); Scale bar, 
 Figure 8-2 CX3CR1
+
 cells uptake ovalbumin in the small intestine.
anesthetized and their intestines were ligated.
ovalbumin conjugated with Alexa Flu
DAPI (A) and CD11c (B
(B); Green, CX3CR1 (C); Grey, Ovalbumin
10 µm. Images are representative of two i
Figure 8-3 OVA-AF647 is 
reconstruction of the SI villus in Figure 8
volume, green marks CX
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or 647 and resected 2 hours later. Sections were stained with 
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ndependent experiments, n = 2.
preferentially captured by CX3CR1
+
 
-2 using Imaris 6.1.0.. The white grid marks the 3D 
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cells. Three-dimensional 
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Thus, cells were isolated from mice fed with DPBS or ovalbumin-AF647 and stained with 
anti-CD103, CD11c and MHC-II antibodies. In the FACS analysis, MHC-II+ CD11c+ cells 
were initially gated; then, three subsets of CD103+, CX3CR1
int and CX3CR1
high cells were 
highlighted.  
Higher percentage of cells positive for OVA-AF647 was observed in the CX3CR1
high and 
CX3CR1
int subsets, while CD103+ cells were almost negative. The kinetic of antigen uptake 
was rapid, with a peak between one and three hours after Ag administration (Figure 8-4, 
A-B). 
When separating the three tracts which form the SI, namely duodenum, jejunum and 
ileum, and staining additionally for CD45 to differentiate epithelial cells, it was evident that 
antigen uptake was unevenly distributed along the small bowel. Indeed, among the total of 
OVA-AF647+ cells, most were CD45-, ranging from about 50% in the duodenum to almost 
95-99% in the jejunum and ileum, outnumbering CX3CR1
int and CX3CR1
high cells. 
In the duodenum, which is the first SI tract reached by the antigen, about 50% of OVA-
AF647+ cells were CX3CR1
int and CX3CR1
high, balancing EC uptake of the antigen (Figure 
8-4, C).   
Hence, we have described a subset of intestinal mononuclear cells, namely CX3CR1
+ 
LPCs, which are mainly involved in Ag uptake in the small intestine.      
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Figure 8-4 CX3CR1
high
 and CX3CR1
int
 cells take up OVA-AF647 in the intestinal lamina propria. 
A-B) 250 µg of ovalbumin-AF647 or DPBS (Vehicle) were i.g. administered to CX3CR1
GFP/+
 mice 
and intestines were collected at the indicated time points. Cells were isolated from the small 
intestines, stained with anti-CD103, MHC-II and CD11c antibodies and analyzed by FACS. 
Percentage of OVA
+
 cells in CD103
+
, CX3CR1
int
 and CX3CR1
high
 subsets is shown in (B). Results 
are representative of two independent experiments, performed with 3 mice / group. Data are shown 
as Mean ± SEM. C) Duodenum, Jejunum and ileum were separately collected and stained with 
CD45 and CD11c antibodies. Ovalbumin
+ 
cells were gated and percentages of each subset among 
total OVA
+
 cells are represented.  
 
8.1.2 Ovalbumin presentation on MHC-I by lamina propria cells depends on 
antigen dose 
 
We further characterized functional OVA peptide presentation on MHC-I taking advantage 
of the Anti-MHC Class I (H-2Kb)-SIINFEKL Antibody, known as anti-KbOVA, 25-D1.16 
[166]. As shown in Figure 8-5, along with CX3CR1
+ LPCs (highlighted by yellow arrows), 
another subset of CD11b+ LP cells was capable of OVA peptide presentation on MHC-I, 
as highlighted by white arrows. Certainly, CD11b marker alone is not sufficient to 
univocally define a subset of antigen presenting cells in the lamina propria. Nevertheless, 
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observing their localization, CD11b+ cells are located where CD11c+ and CD103+ DCs are 
expected in the small intestine.   
Again, we proceeded to FACS analysis in order to more precisely characterize subsets of 
APCs in the lamina propria presenting OVA peptide on MHC-I. Thus, CX3CR1
GFP/+ mice 
were fed with ovalbumin, either at low (1 mg) or high dose (20 mg), and intestines were 
dissected and processed after 8 hours.   
Cells were then stained with MHC-II, CD11c, CD103 and CD11b antibodies to distinguish 
between CX3CR1
+ Mϕ and CD103+ DCs. After exclusion of dead cells, MHC-II
+ CD11c+ 
cells were gated and four main subsets are recognized, CD11b- CD103+, CD11b+ CD103+, 
CX3CR1
int and CX3CR1
high cells. CX3CR1
+ cells uniformly expressed CD11b (as shown in 
Figure 8-6).  
KbOVA antibody is not perfectly suited for FACS staining; nonetheless, a small shift in 
KbOVA histogram was observed when cells display H-2Kb-SIINFEKL marker on their 
surface in a dose-dependent manner. Results were then reported as the difference in the 
Geometric Mean of KbOVA fluorescence between OVA and Vehicle samples for each 
subset.        
When mice were fed with high dose of ovalbumin, at different degrees all the four subsets 
presented OVA peptide on MHC-I. On the other hand, at low Ag dose, which is compatible 
with the dose used for the previous experiments, only CD11b+ CD103+ and CX3CR1
high 
cells presented OVA peptide on MHC-I (Figure 8-7, A-B).    
Hence, the ability of presenting ovalbumin peptides on MHC-I depends on Ag dose. While 
at high dose, this ability is shared among the different LP subsets, at low dose mostly 
CX3CR1
high Mϕ and CD11b+ CD103+ DCs present OVA peptides on MHC-I. We have 
previously shown that CD11b+ CD103+ DCs do not take up antigens by themselves, 
suggesting alternative routes of Ag acquisition.     
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Figure 8-5 CD11b
+
 cells in the lamina propria present OVA on MHC-I complex. Sections of the 
intestinal loop were stained with Anti-CD11b and Anti-MHC Class I (H-2K
b
)-SIINFEKL (K
b
OVA) 
Antibodies. Single channels are shown in the right panels: Green, CX3CR1 (A), Blue, CD11b (B), 
K
b
OVA (C). Merge Picture is shown in (D). White lines represent the villus contour; cells where the 
K
b
OVA signal colocalizes with CD11b signal are indicated by white arrows; cells where K
b
OVA 
signal colocalizes with CX3CR1 are highlighted by yellow arrows. Scale bar, 10 µm. 
 
Figure 8-6 Gating strategy used for the definition of mononuclear cell subsets in the small 
intestine. Cell suspension, obtained by digestion of the tissue, is blocked with anti-CD16-CD32 
antibody and stained with anti-CD45.2, CD11c, MHC-II, CD103 and CD11b antibodies. After 
exclusion of epithelial and dead cells (DAPI
-
 CD45.2
+
), MHC-II
+
 CD11c
+ 
are gated. Three main 
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subsets are subsequently recognized: CD103
+
, CX3CR1
int
 and CX3CR1
high
. The three subsets are 
then divided based on their expression of CD11b; in particular, CD103
+
 DCs are divided as CD11b
-
 
CD103
+
 and CD11b
+
 CD103
+
, while CX3CR1
int
 and CX3CR1
high 
Mϕ express uniformly CD11b.   
  
  
     
 
Figure 8-7 Ovalbumin presentation on MHC-I by LP cells depends on antigen dose. A) After 8 
hours from feeding CX3CR1
GFP/+ 
with DPBS (Vehicle), low (1 mg) or high (20 mg) ovalbumin dose, 
small intestines were dissected and processed. Cells were stained with MHC-II, CD11c, CD103 
and CD11b antibodies and analyzed by FACS. Gating strategy is depicted in (A): after excluding 
dead cells by DAPI staining, MHC-II
+
 CD11c
+
 were gated. They were subsequently distinguished in 
CD11b
- 
CD103
+
, CD11b
+ 
CD103
+
, CX3CR1
int 
and CX3CR1
high 
subsets. Lower panels represent the 
histograms of K
b
OVA fluorescence for each subset. Grey Line, Vehicle; Blue Line, Low Dose 
Ovalbumin; Green Line, High Dose Ovalbumin. B) Results are displayed as Mean ± SEM of the 
difference in the Geometric Mean of K
b
OVA fluorescence between OVA and Vehicle samples for 
each subset. Results are representative of two independent experiments, 4 mice / group. * p < 
0.01.            
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8.1.3 Uptake of ovalbumin by CX3CR1
+ cells is decreased in the absence of 
CX3CR1 receptor 
 
CX3CR1-expressing cells have been for a long time considered a subset of intestinal DCs 
that sample the luminal content and extend dendrites into the intestinal lumen in a 
CX3CR1-dependent manner. In the absence of CX3CR1 receptor, indeed, dendrites are not 
formed [124, 125]. Despite their recent redefinition as intestinal Mϕ, CX3CR1
+ LPCs still 
maintain their functional properties.     
We have previously shown that antigen uptake in the small intestine is preferentially 
carried out by CX3CR1
+ cells; thus, we next asked whether this process is dependent on 
luminal sampling and expression of functional CX3CR1 receptor by these cells.  
We took advantage of CX3CR1
GFP/GFP mice, which have both copies of the CX3CR1 gene 
substituted by the gene coding for GFP. CX3CR1
GFP/+ and CX3CR1
GFP/GFP mice were fed 
with 250 µg of ovalbumin-AF647 and their intestines were removed after 1 h. Organs were 
processed to obtain a cell suspension, which was stained with MHC-II, CD11c, CD103 
and CD11b antibodies. Cells were gated as shown in Figure 8-6.  
For each subset, namely CD11b- CD103+, CD11b+ CD103+, CX3CR1
int and CX3CR1
high 
cells, percentage of OVA+ cells is reported (Figure 8-8). As regards CD11b- CD103+ and 
CD11b+ CD103+ DCs, their poor ability to take up antigens is confirmed and no difference 
is observed between CX3CR1-sufficient and -deficient mice. On the other hand, both 
CX3CR1
int and CX3CR1
high cells show decreased uptake of OVA-AF647 in CX3CR1
GFP/GFP 
compared to CX3CR1
GFP/+ mice, suggesting the involvement of CX3CR1 receptor and 
hence cell protrusions in the sampling and uptake of soluble antigens from the gut lumen.        
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Figure 8-8 Uptake of Ovalbumin-AF647 by CX3CR1
+
 cells in decreased in CX3CR1
GFP/GFP 
mice. 
A) CX3CR1
GFP/+ 
and CX3CR1
GFP/GFP 
mice were i.g. administered with 250 µg of AF647-conjugated 
ovalbumin. After 1 hour, intestines were processed for FACS analysis. After excluding dead cells 
and gating on MHC-II
+
 CD11c
+ 
cells, cells were divided in fours subsets, based on their expression 
of CD103, CX3CR1 and CD11b. Histograms show OVA-AF647 fluorescence for each subset. B) 
Percentage of OVA
+
 cells in each subset is shown. Data are presented as Mean ± SEM and are 
representative of two independent experiments, 4 mice / group.* p < 0.01; n.s. not significant. 
 
8.1.4 Induction of oral tolerance to ovalbumin is impaired in CX3CR1
GFP/GFP 
mice 
 
As the first step in the establishment of oral tolerance - antigen uptake in the SI lamina 
propria - is impaired in CX3CR1
GFP/GFP mice, we wondered whether the lack of functional 
fractalkine receptor would affect the establishment of tolerance to fed antigens at steady-
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state condition. Hence, we evaluated the Delayed type hypersensitivity (DTH) response to 
OVA in C57BL/6, CX3CR1
GFP/+ and CX3CR1
GFP/GFP mice after administration of the same 
antigen through the oral route, as previously described by Goubier et al. [75]. Mice were 
given OVA i.g. at day -13, -10 and -7, immunized subcutaneously with OVA and Complete 
Freund’s Adjuvant (CFA) at day 0 and challenged in the footpad with heat-aggregated 
OVA at day 7. Footpad swelling was measured after 24 and 48 hours. A scheme of DTH 
schedule is shown in Figure 8-9.    
 
 
Figure 8-9 Schedule of Ovalbumin feeding, s.c. immunization and i.f. challenge. Control 
C57BL/6, CX3CR1
GFP/+
 and CX3CR1
GFP/GFP
 mice were fed with 20 mg ovalbumin at day -13, -10 and 
-7. At day 0, they were immunized subcutaneously with 50 µg OVA in Complete Freund’s adjuvant 
and 7 days later were challenged with 250 µg of heat-aggregated OVA in their footpad. DTH 
response was measure as foodpad swelling after 24 and 48 hours from the challenge. 
 
As shown in Figure 8-10, establishment of tolerance to fed OVA was observed in C57BL/6 
and CX3CR1
GFP/+ mice. Indeed, i.g. administration of ovalbumin resulted in a decreased 
DTH response, measured as lessening in the footpad swelling. On the other hand, 
CX3CR1
GFP/GFP mice displayed impaired induction of oral tolerance, as no significant 
difference was observed between DPBS- and OVA-fed mice. 
Similar results were observed in the re-stimulation in vitro of splenocytes derived from 
immunized C57BL/6, CX3CR1
GFP/+ and CX3CR1
GFP/GFP mice, fed or not with ovalbumin. In 
OVA-fed C57BL/6 and CX3CR1
GFP/+ mice, lowering of IFN-γ was observed compared to 
DPBS-fed mice, while no difference was reported for CX3CR1
GFP/GFP mice (Figure 8-11). 
Therefore, we have shown that CX3CR1-deficient mice display decreased Ag uptake by 
CX3CR1
+ cells in the SI and confirmed previous data that they fail to develop tolerance to 
fed antigens [134]. 
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Figure 8-10 Induction of oral tolerance to ovalbumin is impaired in CX3CR1
GFP/GFP
 mice. For 
C57BL/6, CX3CR1
GFP/+
 and CX3CR1
GFP/GFP
 mice, DTH response was evaluated. After 24 and 48 
hours from i.f. challenge with heat-aggregated ovalbumin, footpad swelling was measured as 
difference in the thickness of OVA-challenged and DPBS-injected control footpad for each mouse. 
Results are displayed as Mean ± SEM and are representative of two independent experiments, 3 - 
8 mice / group. * p < 0.05; ** p < 0.01; n.s. not significant. 
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Figure 8-11 In vitro re-stimulation of splenocytes reveals failure of oral tolerance 
establishment in CX3CR1
GFP/GFP 
mice. Splenocytes isolated from DPBS- or OVA-fed C57BL/6, 
CX3CR1
GFP/+
 and CX3CR1
GFP/GFP
 mice were re-stimulated in vitro with 1 mg/ml OVA. Supernatant 
was collected after 4 days and IFN-γ measured by ELISA.  
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8.2 Characterization of antigen transfer among lamina propria cells 
 
8.2.1 Lamina propria cells exchange Ag peptides and a gap-junction 
diffusible dye 
 
Although no or little antigen was detected in CD103+ DCs by FACS staining, we have now 
shown that in the small intestine CD11b+ CD103+ cells, together with CX3CR1
high Mϕ, 
present antigens on MHC-I when Ag is administered at low dose.  
Furthermore, previous studies have shown that CD103+ DCs have proven to be the only 
population of migratory cells endowed with tolerogenic properties once they have reached 
the MLN [103, 104].  
Hence, due the uneven ability of lamina propria cells to phagocytose soluble antigens and 
functionally present them on MHC complexes, we hypothesized that the CX3CR1
+ cells 
may be able to exchange antigenic material with CD103+ cells. 
To test our hypothesis, we sorted SI CD103+ (pooling CD11b- and CD11b+ DCs) and 
CX3CR1
+ cells (pooling CX3CR1
int and CX3CR1
high subsets) from CX3CR1
GFP/+ mice and, 
after loading in vitro with OVA-Alexa Fluor 647, cells were co-cultured for one additional 
hour. The transfer of fluorescent antigens was evaluated by FACS.  
As shown in Figure 8-12, when CX3CR1
+ cells were loaded with ovalbumin and then co-
cultured with CD103+ DCs (third column), around 1% of CD103
+ cells became positive for 
OVA, suggesting a transfer of antigenic material from CX3CR1
+ to CD103+ cells.       
Additionally, the experiment was performed also in the opposite direction, labeling first 
CD103+ DCs, and subsequently co-culturing them with CX3CR1
+ cells (forth column). Of 
note, ex vivo CD103+ DCs efficiently phagocytosed ovalbumin, differently from what 
observed in vivo, and transfered antigens to CX3CR1
+ cells, which become around 4% 
positive for OVA-AF647.      
Therefore, ex vivo both subsets of CX3CR1
+ cells and CD103+ DCs show the capability to 
take up fluorescently-labeled ovalbumin and transfer it to their counterpart. 
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We then asked what possible mechanism might account for Ags exchange between 
CX3CR1
+ cells and CD103+ DCs. Often immune cells release exosomes or cytosol 
fragments in order to communicate to neighboring cells. Alternatively, since these two 
subsets of cells strictly interact in the tissue, one might think that direct connection of 
cytoplasm of adjacent cells can occur. Based on previous know-how acquired in our 
laboratory, we hypothesized that gap junction-mediated transfer may be responsible for 
Ag passage among CX3CR1
+ to CD103+ cells in the small intestine. It has been previously 
shown, indeed, that GJs mediate peptide transfer of small peptides between bone- marrow 
derived dendritic cells [162] and sustain cross-presentation [163, 167].  
In order to test our idea, we asked whether CD11c+ cells purified from the small intestine 
could exchange a GJ-diffusible dye, namely calcein. The experiment was performed as 
depicted in Figure 8-13: the donor fraction of CD11c+ cells (enriched from the small 
intestines of C57BL/6 mice) was loaded with calcein. The acceptor fraction was labeled 
with DDAO, a dye which cannot diffuse through GJ.   
 
Figure 8-12 Ovalbumin peptides can be transferred from CX3CR1
+
 LP cells to CD103
+
 CD11c
+
 
DCs ex vivo, and viceversa. Sorted populations (CX3CR1
+
 LPCs and CD103
+ 
DCs) were cultured 
in the presence (+) or absence (-) of 100 µg/ml Alexa Fluor 647-conjugated ovalbumin for 1 hour 
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and then extensively washed. When indicated, sorted populations were mixed and co-cultured for 1 
h (Yes=co-culture, No=not co-cultured). Transfer of OVA peptides is evaluated by FACS. 
 
Figure 8-13 Experimental scheme to evaluate calcein exchange between pools of CD11c
+
 
cells isolated from the small intestine. CD11c-enriched from the SI of C57BL/6 mice were 
loaded with calcein (donor cells) and then co-cultured with DDAO-loaded CD11c
+ 
cells (acceptor 
cells), as in (B). As a control, DDAO
+
 cells were co-cultured with not labeled CD11c
+
 cells (A). 
Transfer of Calcein to DDAO
+
 cells was evaluated by FACS. In (C), calcein-loaded cells were pre -
treated with 1-Heptanol (at a concentration of 0.5, 5 or 50 mM), a GJ inhibitor, before the co-culture 
with DDAO
+
 cells.  
 
Figure 8-14 Calcein, a gap junction-diffusible dye, is exchanged ex vivo by pools of CD11c
+
 
cells in the small intestine. A) DDAO
+
 cells were co-cultured with not labeled control cells or 
calcein-loaded cells for 30 minutes. Transfer of the dye to DDAO
+
 cells was subsequently 
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evaluated by FACS. When indicated, increasing concentrations of 1-Heptanol were added. B) 
Mean ± SD of the Geometric Mean of FL-1 (Calcein) fluorescence for DDAO
+
 CD11c
+
 cells is 
indicated. Pooled results from three independent experiments are shown, each of them performed 
with CD11c
+ 
cells obtained from 4 C57BL/6 mice.          
 
Donor and acceptor cells were mixed and calcein transfer to DDAO+ cells was evaluated 
by FACS. As shown in Figure 8-14, calcein dye is transferred from Calcein+ CD11c+ cells 
to DDAO+ CD11c+ cells through gap junctions and the process is partly inhibited by the 
pre-treatment of cells with 1-Heptanol, a GJ-blocking agent. Inhibition is obtained already 
at a concentration of 0.5 mM of 1-Heptanol and it is not dose-dependent. 
Taken together, this data suggest that CX3CR1
+ LP cells and CD103+ DCs are able to 
mutually exchange Ags and this process might be mediated by gap junctions. 
 
8.2.2 Small intestine mononuclear cells express a peculiar panel of 
connexins 
 
We next assessed which are the connexins expressed by dendritic cells in the small 
intestine compared to those from mesenteric LNs, spleen and Peyer’s Patches. Hence, 
CD11c+ cells were enriched from these organs and processed for RNA extraction. In 
Figure 8-15, expression of connexins relative to Rlp32 housekeeping gene is shown. For 
each connexin, the expression pattern is highly variable among the different tissues. To 
simplify the results, a threshold was drawn in order to consider only those genes 
characterized by relative expression ≥ 0.001. 
We then isolated CD11c+ cells from different GI tracts. As depicted in Figure 8-16, among 
20 different Connexins encoded in M. musculus genome, GALT DCs express a peculiar 
panel of six connexins, being Cx32 and Cx43 mostly expressed in all the segments of the 
SI.  
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Figure 8-15 Connexin expression by CD11c
+
 cells in the GALT and spleen is tissue-specific. 
CD11c
+ 
cells were enriched from the different tracts of the small intestine (duodenum, jejunum and 
ileum), colon, mesenteric lymph nodes, Peyer’s Patches and spleen. RNA was extracted and 
retrotranscribed. Expression of Cx genes was evaluated by qPCR and normalized to the Rlp32 
housekeeping gene using the 2
-∆Ct 
Method. Results are shown as Mean ± SD of relative expression 
values obtained for three different mice.        
 
Figure 8-16 CD11c
+
 cells isolated from the GALT and spleen express a defined panel of six 
connexins. Connexin genes were filtered based on their relative expression to the housekeeping 
gene (≥ 0.001) and represented as color-coded plot following the scale displayed on the right (from 
blue to red). Results represent the mean of expression values obtained for three different mice.       
 
We next sorted SI MHC-II+ CD11c+ cells from CX3CR1
GFP/+ mice, following the scheme  
indicated in Figure 8-6, and evaluated the expression of the six connexins in CD11b- 
CD103+, CD11b+ CD103+, CX3CR1
int
 and CX3CR1
high subpopulations.  
While Cx26, -31 and -33 were broadly expressed in all the subsets, some displayed a 
subset-specific expression. For instance, Cx32 and -45 were primarily expressed by 
CX3CR1
int
 and CX3CR1
high subpopulations; differently, Cx43 was mainly expressed by 
CX3CR1
int
 and CX3CR1
high Mϕ and CD11b+ CD103+ DCs (Figure 8-17).  
Therefore, we have shown that expression of connexins is highly tissue- and subset-
specific. Moreover, six connexins (Cx26, -31, -32, -33, -43 and -45), and in particular Cx32 
and -43, are the most expressed by CD11c+ cells enriched from the GALT and are 
expressed at different degrees by SI mononuclear cell subsets.     
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Figure 8-17 SI mononuclear cells differentially express Cx genes. Sorted subsets of DCs and 
Mϕ from the small intestine of CX3CR1
GFP/+ 
mice (CD11b
- 
CD103
+
, CD11b
+ 
CD103
+
, CX3CR1
int
 and 
CX3CR1
high
) were lysed and processed for RNA extraction. Expression of the panel of 6 connexins 
was evaluated and reported relative to the expression of the housekeeping Rlp32 gene. Data are 
shown as Mean ± SEM of three samples derived from independent sortings. * p < 0.05, ** p < 0.01     
 
8.3 Characterization of mice lacking Cx43 in CD11c - expressing cells 
 
8.3.1 Generation of mice lacking Cx43 in CD11c - expressing cells 
 
We have hypothesized that GJ-mediated transfer of antigenic material may occur from 
CX3CR1
+ cells, which are endowed with phagocytic ability and uptake soluble antigens 
from the intestinal lumen, to CD103+ DCs, particularly to the CD11b-expressing subset, 
which do not uptake soluble antigens but still present Ag peptides in complex with MHC-I 
at low antigen dose. Besides, we have now observed that a panel of six connexins is 
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differentially expressed among lamina propria cells, and the only one that is concomitantly 
expressed by CX3CR1
+ (both CX3CR1
int and CX3CR1
high) and CD11b+ CD103+ DCs is 
connexin 43.  
In order to test whether antigen transfer mediated by GJs, and in particular by connexin 
43, might be relevant to the first steps of antigen uptake in the small intestine, and more 
generally to the establishment of oral tolerance, Cx43fl/fl mice (B6.129S7-Gja1tm1Dlg/J from 
Jackson Laboratory) were bred to transgenic CD11c-CRE mice (B6.Cg-Tg(Itgax-cre)1-
1Reiz/J) to get Cx43fl/fl CD11c-CRE mice, characterized by deletion of exon 2 in the 
connexin 43 gene only in CD11c-expressing cells, as a result of loxP site-specific 
recombination by CRE recombinase (as shown in Figure 8-18).  
CD11c-driven deletion should target dendritic cells and all the CD11c-expressing immune 
cells.  
Efficient deletion of the exon 2 of connexin 43 was evaluated either by PCR on genomic 
DNA (Figure 8-19) and by qPCR (Figure 8-20) on RNA extracted from CD11c+ cells 
enriched from the small intestine of Cx43fl/fl CD11c-CRE mice.  
As shown in Figure 8-19, an amplicon of 686 bp is amplified by YL49/YL50 primers on 
genomic DNA, as a result of exon 2 deletion. Correctly, that band is observed only in the 
sample derived from Cx43fl/fl CD11c-CRE mice. 
Accordingly, Cx43 expression is reduced in CD11c+ cells enriched from the small intestine 
of Cx43fl/fl CD11c-CRE mice, compared to control mice (Figure 8-20).   
 
 
Figure 8-18 Breeding strategy to obtain Cx43-CD11c mice. Cx43
fl/fl
 and CD11c-CRE mice were 
bred to obtain a generation F1 of mice, characterized by heterozygosity of the Cx43 locus. Mice 
from generation F1 were then bred to obtain a generation F2, where positive mice (bearing Cx43 
Cx43 Locus
loxPloxP
CD11c
CRE Recombinase
Cx43fl/fl mouse CD11c-CRE mouse
F2
CD11c
CRE Recombinase
Cx43 Locus
65 
 
locus in homozygosis and CRE transgene under the control of CD11c promoter) were screened by 
genotyping.            
 
Figure 8-19 Evaluation of efficient deletion of exon 2 of Cx43 gene on genomic DNA 
extracted from SI CD11c
+
 cells. A) Efficient deletion of exon 2 of Cx43 gene can be evaluated by 
PCR on genomic DNA. When exon 2 is deleted, the two loxP sites are brought together and 
YL49/YL50 primers amplify a region of around 700 bp on the genome. B) CD11c
+
 cells were 
enriched from the small intestine of Cx43
fl/fl 
CRE
+
 mice and genomic DNA was extracted. CD11c
+
 
cells from Cx43
fl/fl 
CRE
- 
and
 
Cx43
+/+ 
CRE
+ 
were used as negative controls. When exon 2 of Cx43 
gene is deleted, the 686 bp band is visualized. 
  
       
 
Figure 8-20 Evaluation of Cx43 expression in CD11c
+
 cells enriched from the SI of Cx43
fl/fl 
CD11c-CRE mice. CD11c
+
 cells were enriched from the SI of Cx43
fl/fl 
CD11c-CRE mice and RNA 
was extracted. Cx43 expression is normalized to Rlp32 housekeeping gene. CD11c
+
 cells from 
Cx43
fl/fl 
CRE
- 
and
 
Cx43
+/+ 
CRE
+ 
were used as positive controls. Data are shown as Mean ± SEM, 
from two independent experiments. ** p < 0.01; n.s. not significant.    
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8.3.2 Cx43fl/fl CD11c-CRE mice do not show major differences in LP and 
MLN DC subsets 
 
Lack of connexin 43 has been associated with evident defects of the hematopoietic stem 
cell compartment during embryonic development [160]. In our model Cx43 deletion occurs 
later during DC development, particularly when CD11c begins to be expressed that is at 
the stage of pre-DCs. Nonetheless, we asked whether deletion of Cx43 gene in dendritic 
cells may result in alterations of DC peripheral subsets. 
We firstly analyzed small intestines of Cx43+/+ CD11c-CRE and Cx43fl/fl CD11c-CRE mice. 
Cells were harvested from the organs and stained to evaluate their expression of CD45.2, 
CD11c, MHC-II, CD103 and CD11b markers. Three main subsets of MHC-II+ CD11c+ cells 
were distinguished based on their expression of CD103 and CD11b, namely CD11b- 
CD103+, CD11b+ CD103+ and CD11b+ CD103- (Figure 8-21, A).  
As shown in Figure 8-21, no significant difference was observed either in the percentage 
of MHC-II+ CD11c+ cells (Figure 8-21, B) and in the relative abundance of single subsets 
(Figure 8-21, C).  
The same analysis was repeated for mesenteric lymph nodes; hence, cells obtained from 
digestion of the organs were stained and differentiated on the basis of the previous 
mentioned markers. Four subsets of MHC-II+ CD11c+ dendritic cells were observed in the 
MLN: CD11b- CD103+, CD11b+ CD103+, CD11b+ CD103- and CD11b- CD103- (Figure 8-
22, A). Again, no significant difference was observed both in the percentage of MHC-II+ 
CD11c+ DCs (Figure 8-22, B) and of single DC subsets (Figure 8-22, C), except for the 
CD11b+ CD103- subset. 
Besides, we evaluated the expression of co-stimulatory molecules, such as CD86, CD40 
and CD83, in SI subsets as it has been reported that chemical inhibition of Cx43 in BM-
DCs causes a down-regulation of co-stimulatory molecules, even in the presence of LPS 
or IFN-γ stimulation [162]. As observed in Figure 8-23, we did not observe significant 
difference in the expression of co-stimulatory molecules, except for a slight reduction in 
CD86 expression in CD11b+ CD103- cells.      
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Hence, Cx43 deletion generally affect neither dendritic cell balance in the peripheral 
organs we have considered, namely small intestine and mesenteric lymph nodes, nor the 
expression of co-stimulatory molecules by LP mononuclear cell subsets.  
 
Figure 8-21 Cx43
fl/fl 
CD11c-CRE mice do not display differences in intestinal DC subsets. A) 
Cells were obtained from the small intestine of Cx43
fl/fl
 CD11c-CRE mice and control Cx43
+/+
 
CD11c-CRE and subsequently stained with anti-CD45.2, CD11c, MHC-II, CD103 and CD11b. In 
the analysis, after excluding dead and epithelial cell (DAPI
-
 CD45.2
+
), MHC-II
+ 
CD11c
+
 cells were 
gated. MHC-II
+
 CD11c
+
 cells are then divided based on their expression of CD11b and CD103. 
Three main subsets of CD11b
-
 CD103
+
, CD11b
+
 CD103
+
 and CD11b
+
 CD103
- 
are recognized. B) 
The graph represents the Mean ± SEM of the percentage of MHC-II
+
 CD11c
+
 in the gate DAPI
-
 
CD45.2
+
. C) Mean in the percentage of each subset relative to MHC-II
+
 CD11c
+
 gate is shown for 
Cx43
fl/fl
 CD11c-CRE and Cx43
+/+
 CD11c-CRE mice. Results are shown as Mean ± SEM and are 
representative of two independent experiments, 7 mice / group. * p < 0.05; n.s. not significant. 
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Figure 8-22 Cx43
fl/fl 
CD11c-CRE mice do not display differences in MLN DC subsets. A) Cells 
obtained from the digestion of mesenteric lymph nodes were stained in order to evaluate their 
expression of CD45.2, CD11c, MHC-II, CD103 and CD11b. Dead and stromal cells were excluded, 
gating on DAPI
- 
CD45.2
+
 cells. Among MHC-II
+
 CD11c
+
 cells, four subsets are distinguished based 
on their expression of CD103 and CD11b: CD11b
-
 CD103
+
, CD11b
+
 CD103
+
, CD11b
+
 CD103
- 
and 
CD11b
-
 CD103
-
. B) Percentage of MHC-II
+
 CD11c
+
 among live CD45.2
+
 cells is shown. C) 
Percentage of CD11b
-
 CD103
+
, CD11b
+
 CD103
+
, CD11b
+
 CD103
- 
and CD11b
-
 CD103
-
 cells is 
shown as Mean ± SEM for each subsets. Data are representative of two independent experiments, 
3-4 mice/group. * p < 0.05, n.s. not significant. 
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Figure 8-23 Expression of co-stimulatory molecules by LP subsets is not changed in Cx43
fl/fl 
CD11c-CRE mice. A) Small intestine from Cx43
+/+
 CD11-CRE and Cx43
fl/fl
 CD11c-CRE were 
processed and stained with anti-CD45.2, CD11c, MHC-II, CD103 and CD11b. Besides, expression 
of CD86, CD40 and CD83 co-stimulatory markers were evaluated. Histograms of CD86, CD40 and 
CD83 expression for each subset are shown. The grey line represents the isotype control, the blue 
line stands for Cx43
+/+
 CD11c-CRE, the green for Cx43
fl/fl
 CD11c-CRE. B) Expression of CD86, 
CD40 and CD83 is reported as difference in the Geometric Mean between stained sample and 
isotype control for each subset. Data are representative of two independent experiments, 3-4 mice 
/ group. * p < 0.05.  
 
8.3.3 Lessening of T regulatory cells in the mesenteric lymph nodes is 
caused by lack of Cx43 in CD11c+ cells 
 
In order to gain a general view regarding T cell responses in Cx43fl/fl CD11c-CRE, we 
proceeded with the characterization of different T cell subsets at steady-state. We first 
analyzed T regulatory cells populations in the small intestine and mesenteric lymph 
nodes. Hence, cells were stained with anti-CD3, CD4 and CD8 to define CD4+ T helper 
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and CD8+ T cytotoxic T cells, respectively. CD25 and Foxp3 were used as markers for T 
regulatory cells. 
As shown in Figure 8-24, in the small intestine of Cx43fl/fl CD11c-CRE, there were no 
differences in T regulatory cell frequency, both CD4+ and CD8+, compared to control mice. 
On the other hand, a significant decrease in CD25+ Foxp3+ T regulatory cells, both CD4+ 
and CD8+, was observed in the mesenteric lymph nodes (Figure 8-25). 
 
 
Figure 8-24 Lack of Cx43 in CD11c
+
 cells does not alter peripheral T regulatory cell 
population in the small intestine. A) Mononuclear cells were isolated from the small intestine of 
Cx43
+/+ 
CD11c-CRE and Cx43
fl/fl
 CD11c-CRE and stained with anti - CD45.2, CD3, CD4, CD8, 
Foxp3 and CD25 antibodies. CD45.2
+ 
CD3
+
 T cells were gated and subsequently divided as CD4
+
 
and CD8
+
 T cells. For each population, frequencies of Foxp3
+
 CD25
+
 Tregs are shown. B) Graphs 
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show the frequencies of CD4
+
 (on the left) and CD8
+
 T (on the right) cells among CD45.2
+
 cells. C) 
Graphs represent the percentage of Foxp3
+
 CD25
+ 
among CD4
+
 (on the left) and CD8
+
 (on the 
right) T cells. Data are representative of two independent experiments, 4 mice / group. * p < 0.05, 
n.s. not significant.        
 
 
Figure 8-25 Lack of Cx43 in CD11c
+
 cells is associated with decreased frequency in the Treg 
cell population in the mesenteric lymph nodes. A) Cells obtained from the digestion of MLNs 
were stained with anti-CD45.2, CD3, CD4, CD8, Foxp3 and CD25 antibodies. CD3
+
 cells were 
divided in CD4
+
 and CD8
+
 T cells and frequency of Foxp3
+
 CD25
+
 Tregs was evaluated for each 
population. B) The graph shows the percentage of CD4
+
 (on the left) and CD8
+ 
T (on the right) cells 
among CD45.2
+
 CD3
+
 T cells. C) Frequencies of Foxp3
+
 CD25
+
 Tregs relative to CD4
+ 
CD3
+
 (on 
the left) or CD8
+ 
CD3
+
 T (on the right) cells are shown. Data are representative of two individual 
experiments, performed with 4 mice / group. ** p < 0.01; n.s. not significant.       
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Although really far to be conclusive, data suggest that a peripheral defect in T regulatory 
cells might be a consequence of Cx43 deletion in CD11c+ cells. What is the mechanism 
by which Cx43 deletion in dendritic cells affects Tregs balance, whether it regards the 
peripheral generation of iTregs and how it is related to antigen-specificity of T regulatory 
cell induction are general issues that still need to be addressed. 
 
8.3.4 Tolerance to fed antigens is not established in Cx43fl/fl CD11c-CRE 
mice  
 
Given the reduced level of CD4+ Treg cells in the MLN, we hypothesized that also 
tolerance induction may be impaired in Cx43fl/fl CD11c-CRE mice. 
As a general read out for the establishment of tolerance to i.g. administered Ags, we 
performed a DTH protocol, in order to summarily evaluate the possible contribution of 
Cx43 deletion in CD11c+ cells in oral tolerance. Indeed, if antigens are transferred in the 
SI lamina propria to CD103+ DCs, which are the key players of the tolerogenic response 
generated in the MLN, and Cx43 is involved in that exchange, the net result would be 
defective oral tolerance in Cx43fl/fl CD11c-CRE mice.   
Thus, mice were administered three times with 1 mg ovalbumin every second day and 
immunized s.c. with ovalbumin mixed to Complete Freund’s Adjuvant after 7 days, 
according to the schedule depicted in Fifure 8-9. Mice were then challenged in the footpad 
with heat-aggregated ovalbumin or DPBS as a control and footpad swelling was 
measured as a read out for DTH after 24 and 48 hours.       
As expected, decrease in the footpad swelling of control mice (Cx43+/+ CD11c-CRE) was 
reported after ovalbumin feeding, compared to DPBS-fed mice. On the other hand, 
Cx43fl/fl CD11c-CRE mice showed impairment in oral tolerance establishment, as no 
significant difference was observed between ovalbumin- and vehicle-fed mice. 
These results indicate that, when Cx43 is deleted from CD11c+ cells, oral tolerance is not 
correctly generated. We still do not know at which level Cx43 deletion acts, which are the 
DC cell subsets involved, whether it is the result of defective Ag exchange in the SI or 
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whether it implies general defects in T cell priming and peripheral T regulatory cell 
induction.   
 
Figure 8-26 Induction of oral tolerance to ovalbumin is impaired in Cx43
fl/fl 
CD11c-CRE mice. 
DTH response was evaluated in Cx43
+/+ 
and Cx43
fl/fl
 CD11-CRE mice. Mice were fed with 1 mg 
ovalbumin for three times every second day and immunized s.c. with CFA+OVA after 7 days. 
Seven days later, mice were challenged with heat-aggregated ovalbumin in the footpad and 
footpad swelling was measured after 24 and 48 hours. Difference in the thickness of OVA- 
challenged and DPBS-injected control footpad for each mouse is reported. Results are displayed 
as Mean ± SEM and are representative of one experiment, 6 - 8 mice / group. ** p < 0.01; n.s. not 
significant. 
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9 Discussion  
 
9.1 Role of CX3CR1
+ cells in antigen uptake and oral tolerance 
establishment  
 
The generation of oral tolerance to fed antigens relies on antigen presentation to T cells 
by APCs in the gut-draining lymph nodes. This implies the need for antigens to be taken 
up at the site of administration (the small intestine) and delivered to the mesenteric LNs 
[95].  
Using ovalbumin as a model antigen, we demonstrated that its uptake is limited to 
CX3CR1
+ macrophages in the intestinal lamina propria. Thus, as a result of their close 
proximity to the intestinal lumen and due to their ability to extend their dendrites outside 
the epithelium [97, 124, 126], CX3CR1
+ cells represent the first line by which the immune 
system deals with the luminal content. This seems to be the case also during infections, 
as CD11c+ CX3CR1
+ cells have been shown to hold back S. Typhimurium burden 
especially in its early phase [127, 168] and, eventually, to migrate intra-luminally and 
capture the bacteria [128].  
Differently from what previously shown [97], in our hands antigen uptake by CX3CR1
+ cells 
(both CX3CR1
int and CX3CR1
high Mϕ) seems partially dependent on their expression of 
functional fractalkine receptor and cell protrusion formation [125]. In fact, a decrease in 
the percentage of OVA+ CX3CR1
+ cells is observed in CX3CR1-deficient mice.  
In our experiments, we used a sub-optimal dose of fluorescently-labeled ovalbumin 
administered via the oral route, which may favor Ag uptake by these cells via dendrite 
formation rather than EC paracellular or transcellular leakage. 
As a result of defective antigen uptake, we showed that CX3CR1-deficient mice do not 
develop oral tolerance to fed antigens, in agreement to what has been previously 
published by Hadis et al.. Indeed, it was demonstrated that in CX3CR1-deficient mice, T 
regulatory cells generated in the mesenteric lymph nodes are able to home to the 
intestinal lamina propria but fail to undergo secondary expansion, as a consequence of 
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diminished IL-10 production by CX3CR1
+ cells. We suggest that, in addition to this 
mechanism, at low antigen administration, there is an impairment of T regulatory cell 
development as a consequence of reduced uptake of ovalbumin in the absence of 
CX3CR1. 
In our system, we still lack formal proof that decreased antigen uptake by CX3CR1
+ 
macrophages is linked to impaired peripheral T regulatory cell induction. It would be 
interesting to define whether primary generation of T regulatory cells in the GALT or Tregs 
Ag-specific secondary expansion in the small intestine is affected by decreased antigen 
uptake by CX3CR1
+ cells. This issue will be addressed using an Ag-specific T cell transfer 
model in CX3CR1-sufficient and -deficient mice fed with low ovalbumin dose. 
    
9.2 Role of epithelial cells in antigen uptake 
     
Our data do not exclude a role for epithelial cells in antigen handling. The intestinal 
epithelium has been shown, indeed, to mediate antigen transport by paracellular or 
transcellular pathways [169]. Additionally, intestinal epithelial cells can release exosome-
like vescicles, called “tolerosomes”, which have been isolated on the supernatant of Ag-
treated IEC lines or from the serum of Ag-fed animals [170, 171].   
Besides, it has been recently demonstrated that goblet cells are able to deliver antigens 
directly to CD103+ DCs in the intestinal lamina propria through the formation of GAPs 
(Goblet cell-associated Antigen Passages), but the mechanism seems to be restricted to 
dextran and low-molecular weight Ags [119]. 
In our experiments, OVA+ ECs were detected by FACS, but not by immunofluorescence, 
suggesting alternative ways in which the antigens are intracellularly processed by ECs and 
CX3CR1
+ macrophages. The latter, indeed, display cytosolic aggregates that may favor 
their visualization by immunofluorescence. On the other hand, ECs might rapidly degrade 
and crumble the antigens, allowing their detection by FACS but not by 
immunofluorescence.        
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Moreover, ECs which have taken up fluorescently-labeled ovalbumin outnumber OVA
+ 
CX3CR1
+ cells in the jejunum and ileum, but not in the duodenum. This is in line with 
previous observations made by Chieppa et al. [126], who pointed out that most of the 
protrusions by DCs at steady-state are localized in the first tract of the small intestine. 
Hence, in this region antigen uptake by CX3CR1
+ cells may be preferentially dependent on 
cell protrusion formation. This would explain why only in the duodenum antigen uptake by 
CX3CR1
+ cells counterbalances that of epithelial cells.    
 
9.3 Antigen presentation and transfer by mononuclear cells in the 
lamina propria 
 
While antigen uptake was a characteristic associated primarily to CX3CR1
+ cells, we 
unexpectedly found that when ovalbumin was administered at high dose (20 mg), all the 
subsets of mononuclear cells in the small intestine, namely CD11b- CD103+ DCs, CD11b
+ 
CD103+ DCs, CX3CR1
int and CX3CR1
high macrophages presented OVA peptide on MHC-I 
at different degrees, suggesting a spread diffusion of antigenic peptides in the APC 
subsets.  
On the other hand, also at low antigen dose, CX3CR1
high macrophages and CD11b+ 
CD103+ DCs were preferentially positive for K
bOVA. Thus, based on functional peptide 
presentation on MHC-I, the antigen dose influences ovalbumin presentation by lamina 
propria mononuclear cells but still indicates that CD103+ cells are capable of retrieving the 
antigen in the form of peptides. 
This observation made us consider possible ways on how CD11b+ CD103+ DCs acquire 
antigens, as they were not taking up ovalbumin by themselves.      
Given this functional difference between CX3CR1
+ Mϕ and CD103+ DCs in antigen handling 
in the GALT, our hypothesis is that the former, which efficiently take up and process 
antigens, are then capable of transferring antigens in the form of peptides to CD103+ DCs 
that - due to their inner localization in the villi - might not be able to directly phagocytose 
ovalbumin.  
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Ag presentation by CD103+ DCs appear to be fundamental for Tregs induction in the 
GALT, as they were initially described to be the only DC subset able to migrate to the 
MLNs [97] in a CCR7- [96, 100] and S1P1-S1P3-dependent manner [172] and efficiently 
prime naïve CD4+ and CD8+ T cells [100, 101]. One might now argue that because also a 
subset of CD11b+ CD103- CX3CR1
int cells has been reported to display classical DC 
features, as it is migratory and efficiently prime naïve T cells, may be involved in Treg 
induction. However, differently from CD103+ DCs that drive primarily Tregs, CD11b
+ 
CD103- CX3CR1
int cells seem to polarize T cells toward Th1/Th17 rather than to a T 
regulatory phenotype [113].  
 
How the transfer of peptides between LP mononuclear cells occurs is not known; 
however, it is really frequent for immune cells to exchange cytosol or membrane 
components in order to communicate between each other. For instance, human dendritic 
cells can form filopodia-like structures, called tunnelling microtubules (TNTs) [173], which 
allow to ions and surface proteins to be transferred among cells.  
Besides, mouse dendritic cells have been shown to release exosomes, which are 
originated from the late endosomal compartments fusing with the plasma membrane 
[174]. Released exosomes can reach distant sites and are relevant for their 
immunomodulatory properties [175].          
Furthermore, adjacent cells can transfer ions, metabolites and small peptides through gap 
junctions, which are specialized intercellular connections constituted by hemi-channels of 
connexins directly linking the cytoplasm of neighboring cells. GJs have been shown to 
favor intercellular peptide coupling and transfer to professional APC for cross-presentation 
[163].   
Because we found that CD103+ cells present the OVA peptide but do not seem to have 
the whole protein, it is likely that antigenic transfer occurs in the form of peptides thus 
favoring the possibility that antigen exchange may occur through gap junctions 
established between CX3CR1
+ LPCs and CD103
+ DCs.  
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Constrains regarding the size of exchanged peptides affects GJ-mediated transfer (9 
amino acids in length and 1 KDa as molecular weight), allowing them to be presented in 
complex with MHC-I [163]. Nevertheless, variation in the conformational structure of 
peptides from globular to linear may allow the transfer of longer peptides [176], but 
whether they can be presented in complex with MHC-II has not been addressed yet.   
We observed that SI mononuclear cells can exchange calcein (a GJ diffusible dye) as well 
as ovalbumin peptides and express a peculiar panel of Cxs. Among them, Cx43 is mostly 
expressed both by CX3CR1
+ Mϕ (both CX3CR1
int and CX3CR1
high) and CD11b+ CD103+ 
DCs. 
In order to understand the specific contribution of Cx43 in GJ formation between the 
mononuclear subsets in the LP and its possible involvement in antigen handling in the 
small intestine, we have generated conditional Cx43 knock-out mice in CD11c-expressing 
cells, crossing CD11c-CRE (B6.Cg-Tg(Itgax-cre)1-1Reiz/J) with Cx43fl/fl mice (B6.129S7-
Gja1tm1Dlg/J). 
We are aware that in the gut CX3CR1
+ Mϕ are expressing variable levels of CD11c, which 
may hamper the efficiency of Cx43 deletion in this subset. Particularly in the colon, 
subsets of CX3CR1
high CD11c- macrophages have been described [117]. However, from 
our cell preparations from the small intestine, we observe that both CX3CR1
int and 
CX3CR1
high cells express intermediate to high levels of CD11c. 
The initial characterization of Cx43fl/fl CD11c-CRE mice has shown no defects both in the 
frequency and activation state of mononuclear cell subsets in the SI and MLN compared 
to control mice. However, we found lessened T regulatory cells, both CD4+ and CD8+. The 
decrease in T regulatory cells is accompanied by hampered ability of these mice to 
develop oral tolerance.  
Several scenarios may explain this observation: 1. Cx43 may be involved in the transfer of 
antigenic peptides from CX3CR1
+ to CD103+ cells and hence in the absence of antigen 
transfer DCs are unable to prime Treg cells; 2. Cx43 may be involved in T cell priming and 
hence when DCs lack Cx43 also priming is affected; 3. Gap junctions have been involved 
in cyclic AMP release from DCs to T cells for Treg induction [177] and hence in the 
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absence of Cx43 T regs cannot be induced. We also need to determine whether Cx43 
deletion in CD11c+ cells is affecting only MHC-I presentation by CD103+ DCs or also 
MHC-II presentation.  
 
In conclusion, we have characterized two different aspects of Ag uptake in the SI lamina 
propria, namely ovalbumin uptake by CX3CR1
+ macrophages and antigenic material 
transfer to CD103+ DCs Our results suggest that the preliminary phases of antigen 
handling in the lamina propria are fundamental for the correct establishment of tolerance 
to food antigens. Further experiments are required to fully understand the role of Cx43 in 
either the transfer of antigenic peptides or the activation of T regulatory cells in vivo. 
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